phentolamine has been researched along with Erectile Dysfunction in 326 studies
Phentolamine: A nonselective alpha-adrenergic antagonist. It is used in the treatment of hypertension and hypertensive emergencies, pheochromocytoma, vasospasm of RAYNAUD DISEASE and frostbite, clonidine withdrawal syndrome, impotence, and peripheral vascular disease.
phentolamine : A substituted aniline that is 3-aminophenol in which the hydrogens of the amino group are replaced by 4-methylphenyl and 4,5-dihydro-1H-imidazol-2-ylmethyl groups respectively. An alpha-adrenergic antagonist, it is used for the treatment of hypertension.
Erectile Dysfunction: The inability in the male to have a PENILE ERECTION due to psychological or organ dysfunction.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To compare two injectable treatments, alprostadil 5-20 microg powder for injection and a combination of vasoactive intestinal polypeptide (VIP) and phentolamine in patients with erectile dysfunction (ED)." | 9.12 | Injection therapy for the treatment of erectile dysfunction: a comparison between alprostadil and a combination of vasoactive intestinal polypeptide and phentolamine mesilate. ( Dinsmore, W; Hackett, G; Oakes, RA; Shah, PJ, 2007) |
| "The aim of our work is to evaluate the efficacy of intracavernous sodium nitroprusside (SNP) in management of erectile dysfunction (ED) in a clinical comparative study with papaverine/phentolamine in ED patients." | 9.11 | Intracavernous sodium nitroprusside (SNP) versus papaverine/phentolamine in erectile dysfunction: a comparative study of short-term efficacy and side-effects. ( Abdelsalam, W; Atteya, A; Elnashaar, A; Gadallah, A; Shamloul, R; Zohdy, W, 2005) |
| "The objectives of this study were to evaluate long-term safety and efficacy of phentolamine mesylate, an orally active, rapid-acting alpha-adrenergic receptor antagonist, for the treatment of men suffering from erectile dysfunction (ED)." | 9.10 | Long-term safety and efficacy of oral phentolamine mesylate (Vasomax) in men with mild to moderate erectile dysfunction. ( Auerbach, S; Coogan, C; Goldstein, I; Klimberg, I; Lammers, P; Padma-Nathan, H, 2002) |
| "This open-label, multi-center study from Mexico compared the efficacy and safety of oral sildenafil and phentolamine in men with erectile dysfunction." | 9.10 | Comparison of the efficacy and safety of sildenafil citrate (Viagra) and oral phentolamine for the treatment of erectile dysfunction. ( Hurtado-Coll, A; Ugarte, F, 2002) |
| "Forty-two patients with erectile dysfunction (ED) were randomly assigned to receive SNP 300 micrograms or the control drugs (papaverine 30 mg + phentolamine 1 mg) intracavernously crosswise one week apart." | 9.09 | A clinical comparative study on effects of intracavernous injection of sodium nitroprusside and papaverine/phentolamine in erectile dysfunction patients. ( Fu, Q; Jiang, YQ; Yao, DH, 2000) |
| "After a comprehensive evaluation 44 patients with recent onset (less than 3 years) of erectile dysfunction and a high likelihood of organogenic etiology underwent a prospective, double-blind and placebo controlled trial with oral phentolamine after placebo." | 9.08 | Oral phentolamine as treatment for erectile dysfunction. ( Becker, AJ; Hartmann, U; Jonas, U; Machtens, S; Schultheiss, D; Stief, CG; Truss, MC, 1998) |
| "Recently, nitric oxide was shown to be a mediator of penile erection in men and the nitric oxide donor linsidomine chlorhydrate (SIN-1) was introduced as a novel treatment option in patients with erectile dysfunction." | 9.07 | Role of the nitric oxide donor linsidomine chlorhydrate (SIN-1) in the diagnosis and treatment of erectile dysfunction. ( Becker, AJ; Djamilian, MH; Jonas, U; Stief, CG; Truss, MC, 1994) |
| "In an attempt to determine whether penile pain associated with intracorporeal injections could be due to the acidity of the medication, we performed a randomized study comparing the incidence of penile pain following intracorporeal injections with or without the addition of sodium bicarbonate to the intracorporeal medications." | 9.07 | Sodium bicarbonate alleviates penile pain induced by intracavernous injections for erectile dysfunction. ( Moriel, EZ; Rajfer, J, 1993) |
| "Intracavernosal injection of papaverine and phentolamine was used in 20 patients with impotence." | 9.06 | Medical treatment of impotence with papaverine and phentolamine intracavernosal injection. ( Dinsmore, WW, 1990) |
| "The efficacy of papaverine, and a combination of papaverine and phentolamine as a pharmacological treatment of impotence was compared in a double-blind, crossover trial." | 9.06 | Treatment of impotence by intrapenile injections. A comparison of papaverine versus papaverine and phentolamine: a double-blind, crossover trial. ( Carati, CJ; Earle, CM; Keogh, EJ; Lord, DJ; Tulloch, GS; Watters, GR; Wisniewski, ZS, 1989) |
| " Of 15 men with arteriogenic impotence who had failed prior intracavernous phentolamine and papaverine therapy 10 had adequate erections with prostaglandin E1." | 9.06 | Prostaglandin E1 versus phentolamine/papaverine for the treatment of erectile impotence: a double-blind comparison. ( Lee, LM; Stevenson, RW; Szasz, G, 1989) |
| " The results of a pharmacological test using intracavernously applied mixture of papaverine and phentolamine were compared with the results of a multidisciplinary evaluation of erectile dysfunction." | 9.06 | [Open multicenter study of the differential diagnosis of erectile dysfunction with a papaverine-phentolamine combination (BY023)]. ( Altwein, JE; Baccouche, M; Bähren, W; Jecht, E; Jünemann, KP; Lühmann, R; Müller-Mattheis, V; Weiske, WH; Wetterauer, U; Zentgraf, M, 1988) |
| "To evaluate the efficacy and safety of intracavernous self-injection of phentolamine and papaverine for the treatment of impotence, 30 patients were enrolled in a prospective, randomized, double-blind, placebo-controlled cross-over study of papaverine and phentolamine versus normal saline." | 9.06 | Intracavernous self-injection with phentolamine and papaverine for the treatment of impotence. ( Bruskewitz, RC; Gasser, TC; Larsen, EH; Madsen, PO; Roach, RM, 1987) |
| "Phentolamine mesylate is an alpha-1 and alpha-2 selective adrenergic receptor antagonist which has undergone clinical trials for erectile dysfunction treatment." | 8.80 | Oral phentolamine: an alpha-1, alpha-2 adrenergic antagonist for the treatment of erectile dysfunction. ( Goldstein, I, 2000) |
| "The autors recommend intravenous methylene blue for the treatment of priapism." | 7.72 | Methylene blue as a means of treatment for priapism caused by intracavernous injection to combat erectile dysfunction. ( Hübler, J; Könyves, K; Szántó, A, 2003) |
| "To determine the results of an auto-injection therapy with papaverine-phentolamine (using an auto-injection pen) prescribed by a GP or a urologist, in patients with erectile dysfunction." | 7.71 | [Intracavernous auto-injection therapy with papaverine phentolamine via an auto-injection pen for patients with an erectile dysfunction: similar results achieved in family practice and urology]. ( de Boer, BJ; Kleinjans, HA; Lycklama a Nijeholt, AA, 2001) |
| "The aim of this study was to evaluate the effectiveness of a progressive program for the treatment of erectile dysfunction in patients with cardiovascular disease in whom sildenafil citrate (Viagra) was not an option." | 7.71 | Intracavernous injections for erectile dysfunction in patients with cardiovascular diseases and failure or contraindications for sildenafil citrate. ( Baniel, J; Engelstein, D; Israilov, S; Livne, PM; Niv, E; Segenreich, E; Shmueli, J, 2002) |
| "The effectiveness and complications of intracorporeal phenylephrine without aspiration or irrigation as a treatment for priapism were assessed." | 7.69 | Intracorporeal phenylephrine in the treatment of priapism. ( Hosking, DH; Muruve, N, 1996) |
| "Thirty-three diabetic men were instructed in the use of phentolamine-papaverine injections for the treatment of erectile dysfunction over a two-year period." | 7.68 | Factors predicting efficacy of phentolamine-papaverine intracorporeal injection for treatment of erectile dysfunction in diabetic male. ( Bell, DS; Cutter, GR; Hayne, VB; Lloyd, LK, 1992) |
| "After evaluating approximately 500 patients to identify the cause of erectile dysfunction, I selected 60 patients to receive a therapeutic injection of the vasoactive drugs papaverine and phentolamine mesylate (Regitine) into the corpora cavernosa." | 7.67 | Injections of papaverine and regitine into the corpora cavernosa for erectile dysfunction: clinical results in 60 patients. ( Nelson, RP, 1989) |
| " orally) for persistent penile erection and priapism resulting from injection of pharmacological agents, such as phentolamine, phenoxybenzamine and papavarine, into the penis for erectile impotence." | 7.67 | Treatment of persistent penile erection and priapism using terbutaline. ( Finnerty, DP; Rodriquez, AP; Shantha, TR, 1989) |
| "Ten patients with priapism after self-administered intracavernous papaverine injection for erectile impotence had to be treated as emergencies between September 1985 and February 1988." | 7.67 | [Papaverine-induced priapism. Experiences with a new urologic emergency]. ( Busch, R; Gonnermann, D; Klosterhalfen, H; Schneider, AW, 1989) |
| "In 61 patients with erectile dysfunction a comparative study with intracavernous injection of prostaglandin E1 (PGE1), papaverine and a mixture of papaverine and phentolamine was performed." | 7.67 | [Value of prostaglandin El in the diagnosis of erectile dysfunction in comparison with papaverine and papaverine/phentolamine in 61 patients with erectile dysfunction]. ( Porst, H, 1988) |
| " Studies have shown that sildenafil may not be effective in all patients, and has been associated with a variety of adverse effects and an adverse interaction with nitrates and inhibitors of cytochrome P450 enzymes." | 6.70 | Combination therapy for erectile dysfunction: a randomized, double blind, unblinded active-controlled, cross-over study of the pharmacodynamics and safety of combined oral formulations of apomorphine hydrochloride, phentolamine mesylate and papaverine hyd ( Castaneda, J; Castell, R; Hurley, D; Lammers, PI; Lipezker, M; Loehr, LA; Lowrey, F; Ponce de Leon, R; Rubio-Aurioles, E, 2002) |
| "Papaverine has the greatest deteriorating effect on PGE1." | 5.30 | Vasoactive cocktails for erectile dysfunction: chemical stability of PGE1, papaverine and phentolamine. ( Andrisano, V; Bertaccini, A; Carparelli, F; Cavrini, V; Gotti, R; Martorana, G; Soli, M, 1998) |
| "Twenty men with chronic impotence with a mean age of 46 years (range 26-63 y) were treated with self administration of 0." | 5.29 | A pilot study of the role of intracavernous injection of vasoactive intestinal peptide (VIP) and phentolamine mesylate in the treatment of erectile dysfunction. ( McMahon, CG, 1996) |
| "Priapism was not encountered during self-injection but it did occur twice in 329 physician-administered injections." | 5.28 | Side effects of self-administration of intracavernous papaverine and phentolamine for the treatment of impotence. ( Althof, SE; Bodner, DR; Kursh, ED; Levine, SB; Resnick, MI; Risen, CB; Turner, LA, 1989) |
| "Fourteen patients with organic impotence received intracorporeal injections of papaverine and were then monitored by Rigiscan." | 5.27 | Utility of Rigiscan and papaverine in diagnosis of erectile impotence. ( Badlani, GH; Weinberg, JJ, 1988) |
| "To compare two injectable treatments, alprostadil 5-20 microg powder for injection and a combination of vasoactive intestinal polypeptide (VIP) and phentolamine in patients with erectile dysfunction (ED)." | 5.12 | Injection therapy for the treatment of erectile dysfunction: a comparison between alprostadil and a combination of vasoactive intestinal polypeptide and phentolamine mesilate. ( Dinsmore, W; Hackett, G; Oakes, RA; Shah, PJ, 2007) |
| " A total of 400 patients with erectile dysfunction were evaluated before and after diagnostic intracavernous injection of a trimix solution (papaverine+phentolamine+PGE1) using color Doppler sonography." | 5.11 | The value of penile duplex in the prediction of intracavernous drug-induced priapism. ( Ghanem, HM; Kamel, II; Mousa, AA; Salem, A; Shamloul, R, 2004) |
| "The aim of our work is to evaluate the efficacy of intracavernous sodium nitroprusside (SNP) in management of erectile dysfunction (ED) in a clinical comparative study with papaverine/phentolamine in ED patients." | 5.11 | Intracavernous sodium nitroprusside (SNP) versus papaverine/phentolamine in erectile dysfunction: a comparative study of short-term efficacy and side-effects. ( Abdelsalam, W; Atteya, A; Elnashaar, A; Gadallah, A; Shamloul, R; Zohdy, W, 2005) |
| "The objectives of this study were to evaluate long-term safety and efficacy of phentolamine mesylate, an orally active, rapid-acting alpha-adrenergic receptor antagonist, for the treatment of men suffering from erectile dysfunction (ED)." | 5.10 | Long-term safety and efficacy of oral phentolamine mesylate (Vasomax) in men with mild to moderate erectile dysfunction. ( Auerbach, S; Coogan, C; Goldstein, I; Klimberg, I; Lammers, P; Padma-Nathan, H, 2002) |
| "This open-label, multi-center study from Mexico compared the efficacy and safety of oral sildenafil and phentolamine in men with erectile dysfunction." | 5.10 | Comparison of the efficacy and safety of sildenafil citrate (Viagra) and oral phentolamine for the treatment of erectile dysfunction. ( Hurtado-Coll, A; Ugarte, F, 2002) |
| "Three hundred and four patients with non-psychogenic erectile dysfunction (ED) completed a dose assessment phase with intracavernosal injection utilizing 25 micrograms vasoactive intestinal polypeptide (VIP) combined with phentolamine mesylate 1." | 5.09 | A double blind, placebo controlled study of intracavernosal vasoactive intestinal polypeptide and phenotolamine mesylate in a novel auto-injector for the treatment of non-psychogenic erectile dysfunction. ( Curless, E; Dean, J; Frentz, G; Hackett, G; Liu, S; Oakes, R; Sandhu, D; Savage, D, 1999) |
| "Forty-two patients with erectile dysfunction (ED) were randomly assigned to receive SNP 300 micrograms or the control drugs (papaverine 30 mg + phentolamine 1 mg) intracavernously crosswise one week apart." | 5.09 | A clinical comparative study on effects of intracavernous injection of sodium nitroprusside and papaverine/phentolamine in erectile dysfunction patients. ( Fu, Q; Jiang, YQ; Yao, DH, 2000) |
| "The objective of this study was to determine the effects of oral phentolamine, administered before sleep, on nocturnal penile erectile activity of men with mild to moderate erectile dysfunction (ED)." | 5.09 | Effects of oral phentolamine, taken before sleep, on nocturnal erectile activity: a double-blind, placebo-controlled, crossover study. ( Apostolidis, A; Hatzichristou, DG; Hatzimouratidis, K; Kouvelas, D; Tzortzis, V, 2001) |
| "A study was designed to compare intracorporeal injections of papaverine plus phentolamine (2-drug solution) and papaverine plus phentolamine and prostaglandin E1 (3-drug solution) for the treatment for impotence." | 5.08 | Papaverine-phentolamine and prostaglandin E1 versus papaverine-phentolamine alone for intracorporeal injection therapy: a clinical double-blind study. ( Goldwasser, B; Hanani, J; Shalhav, A; Shenfeld, O; Vardi, Y, 1995) |
| " All patients had presented with erectile dysfunction longer than 6 months in duration and had failed to respond to high doses of papaverine (60 mg." | 5.08 | Prostaglandin E1 versus mixture of prostaglandin E1, papaverine and phentolamine in nonresponders to high papaverine plus phentolamine doses. ( Bechara, A; Casabé, A; Chéliz, G; Fredotovich, N; Romano, S, 1996) |
| "After a comprehensive evaluation 44 patients with recent onset (less than 3 years) of erectile dysfunction and a high likelihood of organogenic etiology underwent a prospective, double-blind and placebo controlled trial with oral phentolamine after placebo." | 5.08 | Oral phentolamine as treatment for erectile dysfunction. ( Becker, AJ; Hartmann, U; Jonas, U; Machtens, S; Schultheiss, D; Stief, CG; Truss, MC, 1998) |
| "Transurethral alprostadil therapy is an effective therapeutic option for patients with erectile dysfunction and may even "rescue" some patients who have failed prior intracavernous injection therapy." | 5.08 | Transurethral alprostadil as therapy for patients who withdrew from or failed prior intracavernous injection therapy. ( Engel, JD; McVary, KT, 1998) |
| "Thirty-eight consecutive men with moderate to severe erectile dysfunction on the basis of history and examination and with minimal or no therapeutic response to intracavernosal alprostadil injection therapy were evaluated." | 5.08 | Combination therapy using oral alpha-blockers and intracavernosal injection in men with erectile dysfunction. ( Kaplan, SA; Kohn, IJ; Reis, RB; Shabsigh, R; Te, AE, 1998) |
| "Recently, nitric oxide was shown to be a mediator of penile erection in men and the nitric oxide donor linsidomine chlorhydrate (SIN-1) was introduced as a novel treatment option in patients with erectile dysfunction." | 5.07 | Role of the nitric oxide donor linsidomine chlorhydrate (SIN-1) in the diagnosis and treatment of erectile dysfunction. ( Becker, AJ; Djamilian, MH; Jonas, U; Stief, CG; Truss, MC, 1994) |
| "In an attempt to determine whether penile pain associated with intracorporeal injections could be due to the acidity of the medication, we performed a randomized study comparing the incidence of penile pain following intracorporeal injections with or without the addition of sodium bicarbonate to the intracorporeal medications." | 5.07 | Sodium bicarbonate alleviates penile pain induced by intracavernous injections for erectile dysfunction. ( Moriel, EZ; Rajfer, J, 1993) |
| "Intracavernosal injection of papaverine and phentolamine was used in 20 patients with impotence." | 5.06 | Medical treatment of impotence with papaverine and phentolamine intracavernosal injection. ( Dinsmore, WW, 1990) |
| "A total of 100 men with organic impotence underwent a trial of intracavernous drug-induced erections with a mixture of papaverine (25 mg." | 5.06 | Intracavernous drug-induced erections in the management of male erectile dysfunction: experience with 100 patients. ( Cameron, JS; Duffy, LM; Lange, PH; Sidi, AA, 1986) |
| "A total of 66 spinal cord injury patients with erectile dysfunction entered a protocol of penile intracavernous pharmacotherapy with papaverine hydrochloride (30 mg." | 5.06 | Vasoactive intracavernous pharmacotherapy for the treatment of erectile impotence in men with spinal cord injury. ( Cameron, JS; Dykstra, DD; Lange, PH; Reinberg, Y; Sidi, AA, 1987) |
| "The efficacy of papaverine, and a combination of papaverine and phentolamine as a pharmacological treatment of impotence was compared in a double-blind, crossover trial." | 5.06 | Treatment of impotence by intrapenile injections. A comparison of papaverine versus papaverine and phentolamine: a double-blind, crossover trial. ( Carati, CJ; Earle, CM; Keogh, EJ; Lord, DJ; Tulloch, GS; Watters, GR; Wisniewski, ZS, 1989) |
| " Of 15 men with arteriogenic impotence who had failed prior intracavernous phentolamine and papaverine therapy 10 had adequate erections with prostaglandin E1." | 5.06 | Prostaglandin E1 versus phentolamine/papaverine for the treatment of erectile impotence: a double-blind comparison. ( Lee, LM; Stevenson, RW; Szasz, G, 1989) |
| " The results of a pharmacological test using intracavernously applied mixture of papaverine and phentolamine were compared with the results of a multidisciplinary evaluation of erectile dysfunction." | 5.06 | [Open multicenter study of the differential diagnosis of erectile dysfunction with a papaverine-phentolamine combination (BY023)]. ( Altwein, JE; Baccouche, M; Bähren, W; Jecht, E; Jünemann, KP; Lühmann, R; Müller-Mattheis, V; Weiske, WH; Wetterauer, U; Zentgraf, M, 1988) |
| "To evaluate the efficacy and safety of intracavernous self-injection of phentolamine and papaverine for the treatment of impotence, 30 patients were enrolled in a prospective, randomized, double-blind, placebo-controlled cross-over study of papaverine and phentolamine versus normal saline." | 5.06 | Intracavernous self-injection with phentolamine and papaverine for the treatment of impotence. ( Bruskewitz, RC; Gasser, TC; Larsen, EH; Madsen, PO; Roach, RM, 1987) |
| "Phentolamine mesylate is an alpha-1 and alpha-2 selective adrenergic receptor antagonist which has undergone clinical trials for erectile dysfunction treatment." | 4.80 | Oral phentolamine: an alpha-1, alpha-2 adrenergic antagonist for the treatment of erectile dysfunction. ( Goldstein, I, 2000) |
| "From the beginning of the eighties papaverine was well established as the drug of choice for diagnosis and management of vasculogenic impotence." | 4.78 | [Endocavernous drug infusions revisited]. ( Bellorofonte, C; Dell'Acqua, S; Ferri, PM; Ruoppolo, M; Tagliaferri, A; Tombolini, P; Yamak, R; Zaatar, C, 1991) |
| "Intracavernous administration of papaverine and phentolamine has become an essential and indispensible element in the diagnosis and treatment of erectile dysfunction." | 4.77 | How safe is the treatment of impotence with intracavernous autoinjection? ( Ludwig, G; Zentgraf, M; Ziegler, M, 1989) |
| " We describe the procedure to establish the dosage for home use and discuss the implications of the low dosages relative to previous reports." | 3.77 | Intracavernous pharmacotherapy for impotence: selection of appropriate agent and dose. ( Donatucci, CF; Kaula, N; Lue, TF; von Heyden, B, 1993) |
| " E1-PG dosage varied from 10 to 40 mcg based on diagnosis, and was readjusted in 6 of the 9 patients which in the initial tests had not obtained sufficient erection, therefore bringing about a final 91." | 3.77 | [Prospective study of the effectiveness and side effects of intracavernous prostaglandin E1 versus papaverine or papaverine phentolamine in the diagnosis and treatment of erection dysfunction. Review of the literature]. ( Alvarez González, E; Chandeck Montesa, K; Chen Jiménez, J; Rodríguez Antolín, A; Tamayo, JC, 1992) |
| "Patients with organic and mixed impotence are best suited for injection treatment, but selected patients with psychogenic impotence also benefit from therapy." | 3.76 | Injection therapy for impotence. ( Althof, SE; Bodner, DR; Kursh, ED; Levine, SB; Resnick, MI; Risen, C; Turner, L, 1988) |
| "The autors recommend intravenous methylene blue for the treatment of priapism." | 3.72 | Methylene blue as a means of treatment for priapism caused by intracavernous injection to combat erectile dysfunction. ( Hübler, J; Könyves, K; Szántó, A, 2003) |
| "This paper reviews laboratory and clinical data concerning oral phentolamine mesylate, Vasomax, an alpha-1, alpha-2 adrenergic receptor antagonist developed specifically for treatment of erectile dysfunction." | 3.71 | Vasomax for the treatment of male erectile dysfunction. ( Carson, C; Goldstein, I; Islam, A; Rosen, R, 2001) |
| "To determine the results of an auto-injection therapy with papaverine-phentolamine (using an auto-injection pen) prescribed by a GP or a urologist, in patients with erectile dysfunction." | 3.71 | [Intracavernous auto-injection therapy with papaverine phentolamine via an auto-injection pen for patients with an erectile dysfunction: similar results achieved in family practice and urology]. ( de Boer, BJ; Kleinjans, HA; Lycklama a Nijeholt, AA, 2001) |
| "Self-injection therapy with papaverine, phentolamine and prostaglandin E1 is effective and safe in the treatment of erectile dysfunction after radical prostatectomy." | 3.71 | Intracavernous injection in the treatment of erectile dysfunction after radical prostatectomy: an observational study. ( Aguiar, W; Andrade, E; Claro, Jde A; de Aboim, JE; Maríngolo, M; Nardozza Júnior, A; Nogueira, M; Srougi, M, 2001) |
| "These results suggest potentially effective combined therapies of sildenafil and intraurethral or intracavernosal prostaglandin-E1, intracavernosal forskolin or VIP, or oral phentolamine for patients with erectile dysfunction who have no success after monotherapy with these agents." | 3.71 | Synergistic effects of sildenafil on relaxation of rabbit and rat cavernosal smooth muscles when combined with various vasoactive agents. ( Jun, IO; Kim, SC; Lee, MY; Oh, MM; Seo, KK, 2001) |
| "The aim of this study was to evaluate the effectiveness of a progressive program for the treatment of erectile dysfunction in patients with cardiovascular disease in whom sildenafil citrate (Viagra) was not an option." | 3.71 | Intracavernous injections for erectile dysfunction in patients with cardiovascular diseases and failure or contraindications for sildenafil citrate. ( Baniel, J; Engelstein, D; Israilov, S; Livne, PM; Niv, E; Segenreich, E; Shmueli, J, 2002) |
| "In vitro and in vivo studies were performed to determine the potential use of tamsulosin (TAM) versus phentolamine (PHE) for intracavernosal injection (ICI) therapy when mixed with papaverine (PAP) and/or prostagladin E1 (PGE1) or with vasoactive intestinal polypeptide (VIP) for the treatment of erectile dysfunction." | 3.70 | Comparison of the synergistic effects of tamsulosin versus phentolamine on penile erection: in vitro and in vivo studies. ( Kim, SC; Lee, MY; Lee, SK; Seo, KK; Song, ES, 1999) |
| "To compare the cost effectiveness of sildenafil and papaverine-phentolamine injections for treating erectile dysfunction." | 3.70 | Cost utility analysis of sildenafil compared with papaverine-phentolamine injections. ( Busschbach, JJ; Caffa, M; Meuleman, EJ; Rutten, FF; Stolk, EA, 2000) |
| "The effectiveness and complications of intracorporeal phenylephrine without aspiration or irrigation as a treatment for priapism were assessed." | 3.69 | Intracorporeal phenylephrine in the treatment of priapism. ( Hosking, DH; Muruve, N, 1996) |
| "Using papaverine, papaverine/phentolamine, or prostaglandin E1 (PGE1), intracavernosal pharmacotherapy has been successful in treating erectile dysfunction." | 3.69 | Experience with intracavernosal tri-mixture for the management of neurogenic erectile dysfunction. ( Chao, R; Clowers, DE, 1994) |
| "We performed a clinical study, erection test with papaverine-phentolamine and neuroandrologic evaluation (bulbocavernous EMG, S2-S4 evoked potentials, evoked somatosensorial potentials, SPACE, D10-L2 skin sympathetic potentials, cystometrogram, and filling videocystography) in 180 patients consulting for impotence." | 3.69 | [Usefulness of the neuroandrologic profile study in patients with erectile dysfunction: review of a series of 180 cases]. ( Aristizábal Agudelo, JM; Blázquez Izquierdo, J; Delgado Martín, JA; Esteban Fuertes, M; Resel Estévez, L; Salinas Casado, J; Samblas García, R; Vírseda Chamorro, M, 1996) |
| "127 patients with impotence were evaluated by neuroandrologic profile, SPACE, erection test post intracavernous injection of papaverine-phentolamine and a cystometrogram (CMG)." | 3.69 | [Evaluation of electromyography of the corpora cavernosa (single potential analysis of cavernous electric activity--SPACE) as a technique for studying impotence]. ( Aristizábal Agudelo, JM; Blázquez Izquierdo, J; Delgado Martín, JA; Esteban Fuertes, M; Resel Estévez, L; Salinas Casado, J; Samblas García, R; Vírseda Chamorro, M, 1997) |
| "A four-drug vasoactive mixture (papaverine hydrochloride, prostaglandin E1, phentolamine mesylate, atropine sulfate) was used for intracavernous injection therapy in 94 patients with vasculogenic impotence as diagnosed by color Doppler sonography and dynamic infusion cavernosometry-cavernosography." | 3.68 | Effectiveness and safety of multidrug intracavernous therapy for vasculogenic impotence. ( Bergamaschi, F; Dodesini, A; Guazzoni, G; Miani, A; Montorsi, F; Pizzini, G; Rigatti, P, 1993) |
| "The corporeal blood gas changes in accordance with the duration of the prolonged erection which developed after intracorporeal pharmacotherapy with papaverine and phentolamine were investigated in 62 impotence patients." | 3.68 | Corporeal blood gas changes according to duration of drug-induced prolonged erection. ( Kim, SC; Oh, CH; Seo, KK, 1993) |
| "We prospectively delineated and contrasted the sexual, marital and psychological responses of women to their partner's use of 2 treatments for erectile dysfunction: 1) self-injection of papaverine and phentolamine, and 2) vacuum tumescence therapy." | 3.68 | Through the eyes of women: the sexual and psychological responses of women to their partner's treatment with self-injection or external vacuum therapy. ( Althof, SE; Bodner, D; Kursh, ED; Levine, SB; Resnick, MI; Turner, LA, 1992) |
| "From May 1985 to July 1989, 143 patients suffering from chronic erectile dysfunction (21-70 years old) underwent constant corpus cavernosum auto-injection therapy (CCAT) with papaverine alone (1257 injections) or with a standardized papaverine-phentolamine mixture (11035 injections)." | 3.68 | [Long-term results of corpus cavernosum auto-injection therapy in treatment of patients with chronic erectile dysfunction]. ( Bähren, W; Gall, H; Holzki, G; Irion, R; Scherb, W; Sparwasser, C, 1992) |
| "Thirty-three diabetic men were instructed in the use of phentolamine-papaverine injections for the treatment of erectile dysfunction over a two-year period." | 3.68 | Factors predicting efficacy of phentolamine-papaverine intracorporeal injection for treatment of erectile dysfunction in diabetic male. ( Bell, DS; Cutter, GR; Hayne, VB; Lloyd, LK, 1992) |
| "Twenty-five men with psychogenic impotence but without serious psychopathology were considered for intracavernosal therapy with papaverine hydrochloride and phentolamine mesylate." | 3.68 | Intracavernous pharmacotherapy in psychogenic impotence. ( Badlani, GH; Ravalli, R; Weiss, JN, 1991) |
| "This study directly compared two nonsurgical treatments for erectile dysfunction, self-injection of papaverine/phentolamine and external vacuum devices, in terms of usage rates, effectiveness, side effects, dropout rates, and impact on patient sexual and psychologic functioning." | 3.68 | Twelve-month comparison of two treatments for erectile dysfunction: self-injection versus external vacuum devices. ( Althof, SE; Bodner, DR; Kursh, ED; Levine, SB; Resnick, MI; Turner, LA, 1992) |
| "The authors present the seamy side of the beneficial practice to handle erectile impotence with papaverine or with the papaverine-Regitin combination." | 3.68 | Induced priapism and its management. ( Götz, F; Jilling, A; Török, A, 1991) |
| "From 1986 to 1989 papaverine was used alone or in combination with phentolamine in 165 patients in diagnosis and treatment of erectile dysfunction." | 3.68 | [Priapism following intracavernous injection of vasoactive substances as a urologic emergency]. ( Papadopoulos, I; Wand, H; Weichert-Jacobsen, K, 1990) |
| "We report 3 cases of penile curvature deformity and fibrosis of the tunica albuginea after long-term self-injection with papaverine hydrochloride and phentolamine mesylate." | 3.67 | Fibrosis of tunica albuginea: complication of long-term intracavernous pharmacological self-injection. ( Burks, C; Christy, WC; Hu, KN, 1987) |
| "This study assessed the sexual, psychosocial, and medical impact of intracavernosal injection of papaverine hydrochloride and phentolamine mesylate in the treatment of impotence." | 3.67 | Intracavernosal injection in the treatment of impotence: a prospective study of sexual, psychological, and marital functioning. ( Althof, SE; Bodner, D; Kursh, ED; Levine, SB; Resnick, M; Risen, C; Turner, LA, 1987) |
| "Of over 300 patients with erectile dysfunction, 186 were selected for intracavernosal autoinjection therapy with a standardized papaverine-phentolamine mixture." | 3.67 | Mid-term results of autoinjection therapy for erectile dysfunction. ( Bähren, W; Gall, H; Scherb, W; Stief, CG, 1988) |
| " phentolamine mesylate used to induce erection in patients with impotence was examined." | 3.67 | Physicochemical stability of papaverine hydrochloride-phentolamine mesylate mixtures used for intracavernous injection: a preliminary evaluation. ( Hadzija, BW; Mattocks, AM; Stahl, GM, 1988) |
| "After evaluating approximately 500 patients to identify the cause of erectile dysfunction, I selected 60 patients to receive a therapeutic injection of the vasoactive drugs papaverine and phentolamine mesylate (Regitine) into the corpora cavernosa." | 3.67 | Injections of papaverine and regitine into the corpora cavernosa for erectile dysfunction: clinical results in 60 patients. ( Nelson, RP, 1989) |
| "The usefulness of a chemical prosthesis was studied for the diagnosis and treatment of 20 patients with erectile impotence (14 due to diabetes, 2 due to pelvic surgery and 4 due to psychogenic factors) using papaverine hydrochloride and phentolamine mesilate." | 3.67 | [Diagnosis and treatment of impotence with administration of chemical prosthesis using real-time mechanical sector duplex scanner--with special reference to diabetic patients]. ( Kaneda, S; Matsuoka, K; Nakajima, Y; Shibayama, T; Suzuki, Y; Yamamoto, H, 1989) |
| " In the current study, we evaluated 40 SCI patients and 116 patients with vascular based impotence who had been followed for a minimum of 1 month while utilising intracavernous injections of phentolamine and papaverine." | 3.67 | Intracavernous pharmacotherapy for management of erectile dysfunction in spinal cord injury. ( Lloyd, LK; Richards, JS, 1989) |
| " orally) for persistent penile erection and priapism resulting from injection of pharmacological agents, such as phentolamine, phenoxybenzamine and papavarine, into the penis for erectile impotence." | 3.67 | Treatment of persistent penile erection and priapism using terbutaline. ( Finnerty, DP; Rodriquez, AP; Shantha, TR, 1989) |
| "Ten patients with priapism after self-administered intracavernous papaverine injection for erectile impotence had to be treated as emergencies between September 1985 and February 1988." | 3.67 | [Papaverine-induced priapism. Experiences with a new urologic emergency]. ( Busch, R; Gonnermann, D; Klosterhalfen, H; Schneider, AW, 1989) |
| "One hundred and twenty five men with psychogenic or organic impotence used autoinjection of the penile corpora cavernosa with either papaverine or papaverine and phentolamine for a mean period of 10." | 3.67 | Impotence: treatment by autoinjection of vasoactive drugs. ( Kiely, EA; Mulcahy, MJ; Williams, G, 1987) |
| "Intracavernosal self-injection of smooth muscle relaxants, primarily papaverine admixed with phentolamine, have been used to treat impotence in over 300 patients." | 3.67 | Therapeutic roles of intracavernosal papaverine. ( Goldstein, I; Padma-Nathan, H; Payton, T, 1988) |
| "Although the intracorporeal injection of mixtures of phentolamine and papaverine is used commonly in the diagnosis and treatment of erectile dysfunction, pharmacological data relating to the stability of such drug mixtures are lacking." | 3.67 | Is phentolamine stable in solution with papaverine. ( Benson, GS; Seifert, WE, 1988) |
| "A total of 78 patients 17 to 84 years old reported their experience via questionnaire with the papaverine-phentolamine injection technique for impotence." | 3.67 | Intracavernous self-injection for impotence: a long-term therapeutic option? Experience in 78 patients. ( Bruskewitz, RC; Feyzi, J; Gasser, TC; Girdley, FM; Graversen, PH, 1988) |
| "In 61 patients with erectile dysfunction a comparative study with intracavernous injection of prostaglandin E1 (PGE1), papaverine and a mixture of papaverine and phentolamine was performed." | 3.67 | [Value of prostaglandin El in the diagnosis of erectile dysfunction in comparison with papaverine and papaverine/phentolamine in 61 patients with erectile dysfunction]. ( Porst, H, 1988) |
| " papaverine) for the treatment of erectile dysfunction." | 3.67 | Prolonged erections following intracorporeal injection of medications to overcome impotence. ( Carati, CJ; Earle, CM; Keogh, EJ; Lord, DJ; Tulloch, AG; Watters, GR; Wisniewski, ZS, 1988) |
| "Eight patients with impotence following radical cystectomy and ileal loop surgery for cancer of the bladder were treated with a mixture of papaverine/phentolamine at 30/1 ratio." | 3.67 | Penile self-injection for impotence in patients after radical cystectomy-ileal loop. ( Al-Juburi, AZ; O'Donnell, PD, 1987) |
| "We report on our results with the intracavernous injection and self-injection of papaverine-phentolamine in a group of spinal cord injury patients with erectile impotence." | 3.67 | Intracavernous injection of vasoactive drugs, an alternative for treating impotence in spinal cord injury patients. ( Claessens, H; de Meyer, JM; de Sy, WA; Wyndaele, JJ, 1986) |
| "Thirty-eight patients with predominantly organic and 29 with psychogenic impotence had intracavernosal injections of a combination of 30 mg papaverine and 1 mg phentolamine on at least one occasion." | 3.67 | Assessment of the immediate and long-term effects of pharmacologically induced penile erections in the treatment of psychogenic and organic impotence. ( Goldie, L; Kiely, EA; Williams, G, 1987) |
| " The dosage of sildenafil and phentolamine was respectively 50-100 mg and 40 mg." | 2.71 | [Assessment of curative effect on erectile dysfunction of two drugs]. ( Jiao, Y; Ma, XN; Yang, DZ; Yu, ZJ, 2003) |
| " Studies have shown that sildenafil may not be effective in all patients, and has been associated with a variety of adverse effects and an adverse interaction with nitrates and inhibitors of cytochrome P450 enzymes." | 2.70 | Combination therapy for erectile dysfunction: a randomized, double blind, unblinded active-controlled, cross-over study of the pharmacodynamics and safety of combined oral formulations of apomorphine hydrochloride, phentolamine mesylate and papaverine hyd ( Castaneda, J; Castell, R; Hurley, D; Lammers, PI; Lipezker, M; Loehr, LA; Lowrey, F; Ponce de Leon, R; Rubio-Aurioles, E, 2002) |
| " Patients were treated with sildenafil citrate alone or in combination with intracavernosal injection therapy." | 2.69 | Treatment of intracorporeal injection nonresponse with sildenafil alone or in combination with triple agent intracorporeal injection therapy. ( Johnson, H; McMahon, CG; Samali, R, 1999) |
| "We performed a double-blind, crossover study using objective measurements to compare maximum rigidity and duration of erections with papaverine hydrochloride in combination with phentolamine mesylate and/or prostaglandin E1." | 2.67 | Objective double-blind evaluation of erectile function with intracorporeal papaverine in combination with phentolamine and/or prostaglandin E1. ( Allen, RP; Brendler, CB; Engel, RM; Smolev, JK, 1992) |
| "Men with impotence of any etiology have been entered on a program to evaluate prospectively the efficacy of intracavernosal injection of vasoactive compounds in producing a satisfactory erection with pharmacologic means." | 2.67 | Pharmacologic erection with intracavernosal injection for men with sexual dysfunction following irradiation: a preliminary report. ( English, W; Goodman, RL; Hanno, PM; Pierce, LJ; Wein, AJ; Whittington, R, 1991) |
| "The organic nature of the impotence was documented with nocturnal penile tumescence testing, sacral latency examination, Doppler penile blood flow measurements, hormonal evaluation and psychological testing." | 2.66 | Effect of local alpha-adrenergic blockade on human penile erection. ( Bahnson, RR; Blum, MD; Carter, MF; Porter, TN, 1985) |
| " At this dosage prostaglandin E1 was most effective in inducing artificial penile erection (11 of 12 patients)." | 2.66 | Efficiency and side effects of prostaglandin E1 in the treatment of erectile dysfunction. ( Schramek, P; Waldhauser, M, 1988) |
| "Apomorphine SL is a dopamine D1- and D2-receptor agonist which has recently been approved for marketing in Europe." | 2.42 | Pharmacological management of erectile dysfunction. ( Cestari, A; Deho', F; Guazzoni, G; Montorsi, F; Rigatti, P; Salonia, A; Stief, C, 2003) |
| "Discussion of erectile dysfunction has increased, information about erectile dysfunction is increasingly available, training in erectile dysfunction was improved and last, but not least, the number of patients seeking help for erectile dysfunction is growing, because satisfactory sexual function is an important part of a couple's healthy relationship and ongoing quality of life." | 2.42 | The etiology of erectile dysfunction and mechanisms by which drugs improve erection. ( Gallé, G; Trummer, H, 2003) |
| "Erectile dysfunction (ED) (impotence) is a widespread, age-related problem, which affects 52% of men between 40 and 70 years of age." | 2.41 | Erectile dysfunction: oral pharmacotherapy options. ( Pelcic, JM; Vitezic, D, 2002) |
| "The treatment of erectile dysfunction has changed dramatically over the past two decades." | 2.41 | Oral and injectable medications for the treatment of erectile dysfunction. ( Carson, CC, 2000) |
| "Pharmacological treatment of erectile dysfunction includes all therapeutic modalities based on the use of erectogenic drugs, regardless of the route of administration." | 2.39 | Pharmacological management of erectile dysfunction. ( Guazzoni, G; Montorsi, F; Pozza, G; Rigatti, P, 1995) |
| "In recent years the true incidence of impotence due to organic diseases in comparison with psychogenic disorders could be verified." | 2.38 | [Current diagnosis of impotence]. ( Bast, R; Drawz, B; Drawz, G; Eilitz, B; Hasse, N; Heydel, E; Heydenreich, A; Kmietzyk, HJ; Schultz, J; Seemann, B, 1990) |
| " To minimize complications, careful selection of candidates, cautious dosage determination, and thorough instruction on injection technique are mandatory." | 2.37 | Vasoactive intracavernous pharmacotherapy. ( Sidi, AA, 1988) |
| "Priapism is a major side effect of ICI therapy and an uncommon, although important, side effect of other conditions." | 1.32 | The incidence and management of priapism in Western Australia: a 16 year audit. ( Ching, HL; Earle, CM; Stuckey, BG; Wisniewski, ZS, 2003) |
| "Papaverine has the greatest deteriorating effect on PGE1." | 1.30 | Vasoactive cocktails for erectile dysfunction: chemical stability of PGE1, papaverine and phentolamine. ( Andrisano, V; Bertaccini, A; Carparelli, F; Cavrini, V; Gotti, R; Martorana, G; Soli, M, 1998) |
| " This progressive method of treatment enabled us to select the optimal dosage and combinations of compounds in 441/452 patients (97." | 1.30 | [Evaluation of 452 patients with erectile dysfunction treated by combinations of vasoactive agents by penile injection]. ( Baniel, J; Israilov, S; Livne, P; Segenreich, E; Shmueli, J; Simon, D, 1998) |
| "During impotence evaluations a positive intracavernous injection test has been presumed to signify normal erectile hemodynamics." | 1.29 | A positive intracavernous injection test implies normal veno-occlusive but not necessarily normal arterial function: a hemodynamic study. ( Goldstein, I; Hatzichristou, DG; Namburi, S; Pescatori, ES, 1994) |
| "atropine sulfate was used." | 1.29 | Four-drug intracavernous therapy for impotence due to corporeal veno-occlusive dysfunction. ( Barbieri, L; Bergamaschi, F; Ferini-Strambi, L; Guazzoni, G; Montorsi, F; Rigatti, P, 1993) |
| "The management of their impotence was aso reviewed." | 1.29 | Impotence following pelvic fracture urethral injury: incidence, aetiology and management. ( Keane, TE; Mark, SD; Vandemark, RM; Webster, GD, 1995) |
| "Treatments for impotence include injection therapy, vacuum devices, and implants." | 1.29 | Love and sex after 60: how to evaluate and treat the impotent older man. A roundtable discussion: Part 2. ( Butler, RN; Hoffman, E; Lewis, MI; Whitehead, ED, 1994) |
| "Scarring was documented in 7 of 170 patients (4." | 1.29 | Experience with triple-drug therapy in a pharmacological erection program. ( Gibbons, RP; Govier, FE; Kramer-Levien, D; McClure, RD; Pritchett, TR; Weissman, RM, 1993) |
| " We conclude that self-injection with a combination of papaverine and phentolamine is an efficient and safe long-term treatment for erectile dysfunction." | 1.29 | [Effectiveness and safety of cavernous body auto-injection therapy with papaverine/phentolamine. Study group]. ( Hartmann, U; Thon, WF, 1993) |
| "Sensitivity and specificity were calculated for each side separately." | 1.29 | [A comparison of color duplex sonography with selective penile DSA in assessing erectile dysfunction]. ( Bautz, W; Brandstetter, K; Lenz, M; Pickl, U; Schwarzer, JU, 1993) |
| "Twenty men with chronic impotence with a mean age of 46 years (range 26-63 y) were treated with self administration of 0." | 1.29 | A pilot study of the role of intracavernous injection of vasoactive intestinal peptide (VIP) and phentolamine mesylate in the treatment of erectile dysfunction. ( McMahon, CG, 1996) |
| "If we define erectile impotence as the inability to achieve and maintain a firm erection we can distinguish several pathogens of impotence: psychologic disorders, neurogenic sinusoidal disorders, arterial disorders, venous & sinusoidal disorders and systemic diseases and other disorders can cause erectile impotence." | 1.28 | [Impotence: introductory notes]. ( Belgrano, E; Deriu, M; Pirozzi-Farina, F; Salisci, E; Siracusano, S; Trombetta, C, 1992) |
| "Impotence was classified as psychogenic in 3 patients, psychogenic/arteriogenic in 3, arteriogenic in 25, arteriogenic/neurogenic in 4, neurogenic in 5, venous leakage/psychogenic in 2, venous leakage/neurogenic in 1 and following venous leak surgery in 9." | 1.28 | Intracavernous self-injection with vasoactive intestinal polypeptide and phentolamine in the management of erectile failure. ( Fahrenkrug, J; Gerstenberg, TC; Metz, P; Ottesen, B, 1992) |
| " A portable home nocturnal tumescence monitor classification of severity of sexual dysfunction provided a guideline for the intracavernous pharmacological injection initial dosage and the probability of success or failure in patients who desire this form of therapy for male sexual dysfunction." | 1.28 | Classification of sexual dysfunction for management of intracavernous medication-induced erections. ( Fein, RL, 1990) |
| " This vasoactive drug combination has been used in 116 patients for diagnostic testing and subsequent treatment." | 1.28 | An improved vasoactive drug combination for a pharmacological erection program. ( Barada, JH; Bennett, AH; Carpenter, AJ, 1991) |
| "Impotence affects about 10% of all men." | 1.28 | [Intracavernous pharmacotherapy for treatment and evaluation of impotence]. ( Levin, RD; Lidgi, S; Moskovitz, B; Vardi, Y, 1991) |
| "To characterize better elderly men with impotence, and determine whether intracavernous injection therapy is safe and effective in this age group, a retrospective analysis was performed upon patients attending the male sexual dysfunction clinic at our university medical center who received a standard papaverine and phentolamine mixture (30 mg." | 1.28 | Pharmacologically induced erections among geriatric men. ( Carson, CC; Kerfoot, WW, 1991) |
| "A total of 50 patients with impotence underwent cavernosometry and cavernosography with intracavernous injection of vasoactive drugs." | 1.28 | Venous leaks: anatomical and physiological observations. ( Fishman, IJ; Shabsigh, R; Skolkin, M; Toombs, BD, 1991) |
| " prostaglandin E1 in combination with papaverine (although the difference is not statistically significant)." | 1.28 | Intracavernous injection of prostaglandin E1 in combination with papaverine: enhanced effectiveness in comparison with papaverine plus phentolamine and prostaglandin E1 alone. ( Floth, A; Schramek, P, 1991) |
| " While intracavernosal VIP alone produced disappointing penile responses, its combination with papaverine potentiated the response to this drug, probably by increasing venous outflow resistance." | 1.28 | Penile response to intracavernosal vasoactive intestinal polypeptide alone and in combination with other vasoactive agents. ( Bloom, SR; Kiely, EA; Williams, G, 1989) |
| "Priapism was not encountered during self-injection but it did occur twice in 329 physician-administered injections." | 1.28 | Side effects of self-administration of intracavernous papaverine and phentolamine for the treatment of impotence. ( Althof, SE; Bodner, DR; Kursh, ED; Levine, SB; Resnick, MI; Risen, CB; Turner, LA, 1989) |
| " The dosage of phentolamine mesylate-papaverin hydrochloride injection required was determined in each patient individually." | 1.27 | [Corpus cavernosum autoinjection therapy: initial experiences in erectile dysfunction]. ( Altwein, JE; Bähren, W; Gall, H; Gallwitz, A; Scherb, W; Stief, CG, 1986) |
| "At the Nashville Impotence Center we use intracavernous injections of papaverine-phentolamine to diagnose vascular impotence and to treat certain patients with organic impotence as well as some patients with psychologic impotence." | 1.27 | Pharmacologic erection program for the treatment of male impotence. ( Trapp, JD, 1987) |
| "Priapism was the most significant complication and occurred in 8." | 1.27 | Pharmacological erection: diagnosis and treatment applications in 69 patients. ( Ellis, LR; Kramer-Levien, D; Nellans, RE, 1987) |
| "Fourteen patients with organic impotence received intracorporeal injections of papaverine and were then monitored by Rigiscan." | 1.27 | Utility of Rigiscan and papaverine in diagnosis of erectile impotence. ( Badlani, GH; Weinberg, JJ, 1988) |
| "Diabetic microangiopathy is regarded as the most important pathogenic factor." | 1.27 | [Disorders of erectile potency in diabetes mellitus]. ( Floth, A; Holzmann, RM; Schramek, P, 1988) |
| "Phentolamine was added if 80 mg was not sufficient." | 1.27 | Intracavernous self-injection for erectile failure. ( Alfthan, O; Lindström, BL; Ruutu, M; Virtanen, J, 1988) |
| "Sixteen of 149 patients complaining of impotence of a non-neurogenic or endocrine aetiology and with a penile brachial index of greater than 0." | 1.27 | Diagnosis and treatment of venous leakage: a curable cause of impotence. ( Hartnell, G; Kiely, E; Mulcahy, MJ; Williams, G, 1988) |
| " Two patients who failed to achieve erections had the lowest penile brachial index values and 1 in whom priapism developed had the highest value, indicating that this may be a useful technique to determine the initial dosage of the injection." | 1.27 | Pharmacological treatment of erectile dysfunction after radical prostatectomy. ( Dennis, RL; McDougal, WS, 1988) |
| "For vasculogenic impotence response rate depended upon impairment severity determined from nocturnal penile tumescence measurements; none of the severe cases versus 90 per cent of the milder cases responded." | 1.27 | Nocturnal penile tumescence predicting response to intracorporeal pharmacological erection testing. ( Allen, RP; Brendler, CB, 1988) |
| "Until recently, the only treatments for impotence were testosterone injection, sex therapy, and implantation of a penile prosthesis." | 1.27 | Treatment of impotence. 1. Nonsurgical methods. ( Baum, N, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 108 (33.13) | 18.7374 |
| 1990's | 146 (44.79) | 18.2507 |
| 2000's | 66 (20.25) | 29.6817 |
| 2010's | 6 (1.84) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, GY | 1 |
| Xu, CC | 1 |
| Wu, KR | 1 |
| Liu, GL | 1 |
| Zhang, J | 1 |
| Pan, YN | 1 |
| Tang, YF | 1 |
| Duncan, C | 1 |
| Omran, GJ | 1 |
| Teh, J | 1 |
| Davis, NF | 1 |
| Bolton, DM | 1 |
| Lawrentschuk, N | 1 |
| Nelson, CJ | 1 |
| Hsiao, W | 1 |
| Balk, E | 1 |
| Narus, J | 1 |
| Tal, R | 1 |
| Bennett, NE | 1 |
| Mulhall, JP | 2 |
| Sung, HH | 1 |
| Ahn, JS | 1 |
| Kim, JJ | 1 |
| Choo, SH | 1 |
| Han, DH | 1 |
| Lee, SW | 2 |
| Zargooshi, J | 1 |
| Wyllie, MG | 2 |
| Salem, H | 1 |
| Mostafa, T | 1 |
| Thomas, JA | 1 |
| Hatzichristou, D | 1 |
| Hatzimouratidis, K | 4 |
| Bekas, M | 1 |
| Apostolidis, A | 3 |
| Tzortzis, V | 2 |
| Yannakoyorgos, K | 2 |
| Padma-Nathan, H | 4 |
| Goldstein, I | 7 |
| Klimberg, I | 1 |
| Coogan, C | 1 |
| Auerbach, S | 1 |
| Lammers, P | 1 |
| Ugarte, F | 1 |
| Hurtado-Coll, A | 1 |
| Horita, H | 1 |
| Sato, Y | 1 |
| Tsukamoto, T | 1 |
| Asuar Aydillo, S | 1 |
| Vitezic, D | 1 |
| Pelcic, JM | 1 |
| Speel, TG | 2 |
| van Langen, H | 1 |
| Wijkstra, H | 2 |
| Meuleman, EJ | 5 |
| Montorsi, F | 6 |
| Salonia, A | 1 |
| Deho', F | 1 |
| Cestari, A | 1 |
| Guazzoni, G | 6 |
| Rigatti, P | 6 |
| Stief, C | 3 |
| Gallé, G | 1 |
| Trummer, H | 2 |
| Palea, S | 1 |
| Barras, M | 1 |
| Jian, HY | 1 |
| Hao, JC | 1 |
| Yang, DZ | 1 |
| Ma, XN | 1 |
| Yu, ZJ | 1 |
| Jiao, Y | 1 |
| Earle, CM | 5 |
| Stuckey, BG | 1 |
| Ching, HL | 1 |
| Wisniewski, ZS | 4 |
| Pagani, E | 2 |
| Glina, S | 2 |
| Puech-Leão, P | 2 |
| Strunz, CM | 1 |
| Chao, S | 1 |
| Timo-Iaria, C | 1 |
| DANIELL, HW | 1 |
| Raina, R | 2 |
| Lakin, MM | 6 |
| Thukral, M | 1 |
| Agarwal, A | 2 |
| Ausmundson, S | 2 |
| Montague, DK | 7 |
| Klein, E | 1 |
| Zippe, CD | 2 |
| McMahon, CG | 3 |
| Shamloul, R | 3 |
| Ghanem, HM | 2 |
| Salem, A | 1 |
| Kamel, II | 2 |
| Mousa, AA | 1 |
| Moemen, MN | 1 |
| Hamed, HA | 1 |
| Shamloul, RM | 1 |
| Sharabi, FM | 1 |
| Daabees, TT | 1 |
| El-Metwally, MA | 1 |
| Senbel, AM | 1 |
| Hübler, J | 1 |
| Szántó, A | 1 |
| Könyves, K | 1 |
| Schultheiss, D | 2 |
| Pilatz, A | 1 |
| Gabouev, AI | 1 |
| Schlote, N | 1 |
| Wefer, J | 1 |
| Mertsching, H | 1 |
| Sohn, M | 1 |
| Jonas, U | 5 |
| Stief, CG | 19 |
| Hatzichristou, DG | 5 |
| Dinsmore, WW | 5 |
| Pescatori, ES | 4 |
| Morgia, G | 1 |
| Pirozzi-Farina, F | 2 |
| Farina, FP | 1 |
| Mittmann, N | 1 |
| Craven, BC | 1 |
| Gordon, M | 1 |
| MacMillan, DH | 1 |
| Hassouna, M | 2 |
| Raynard, W | 1 |
| Kaiser, A | 1 |
| Lanctôt, LK | 1 |
| Tarride, JE | 1 |
| Atteya, A | 1 |
| Elnashaar, A | 1 |
| Gadallah, A | 2 |
| Zohdy, W | 1 |
| Abdelsalam, W | 1 |
| El-Dakhly, M | 1 |
| Ghanem, H | 2 |
| Mokhtar, H | 1 |
| Tarhan, F | 1 |
| Canguven, O | 1 |
| Kuyumcuoglu, U | 1 |
| Huang, ST | 1 |
| Hsieh, ML | 1 |
| Shah, PJ | 1 |
| Dinsmore, W | 1 |
| Oakes, RA | 1 |
| Hackett, G | 2 |
| Brindley, GS | 1 |
| Muruve, N | 1 |
| Hosking, DH | 1 |
| Hayashi, S | 1 |
| Iwai, Y | 1 |
| Yasumoto, R | 2 |
| Matsuda, J | 1 |
| Kawano, M | 1 |
| Omachi, T | 1 |
| Kono, T | 1 |
| Yamamoto, S | 1 |
| Sakakura, T | 1 |
| Minami, H | 1 |
| Namburi, S | 2 |
| Zorgniotti, AW | 5 |
| Shenfeld, O | 1 |
| Hanani, J | 1 |
| Shalhav, A | 1 |
| Vardi, Y | 3 |
| Goldwasser, B | 1 |
| Bergamaschi, F | 4 |
| Ferini-Strambi, L | 1 |
| Barbieri, L | 2 |
| Orlandini, A | 1 |
| Da Pozzo, L | 1 |
| Dodesini, A | 1 |
| Pizzini, G | 2 |
| Miani, A | 2 |
| Meinhardt, W | 2 |
| Lycklama à Nijeholt, AA | 4 |
| Kropman, RF | 1 |
| Vermeij, P | 2 |
| Zwartendijk, J | 2 |
| Porst, H | 4 |
| Mark, SD | 1 |
| Keane, TE | 1 |
| Vandemark, RM | 1 |
| Webster, GD | 1 |
| Saenz de Tejada, I | 2 |
| Kupferman, S | 1 |
| Udelson, D | 1 |
| Rodilla, F | 1 |
| Fuentes, MD | 1 |
| Chuan, P | 1 |
| Ferriols, F | 1 |
| Magraner, J | 1 |
| Butler, RN | 1 |
| Lewis, MI | 1 |
| Hoffman, E | 1 |
| Whitehead, ED | 1 |
| Sparwasser, C | 4 |
| Drescher, P | 1 |
| Pust, RA | 1 |
| Madsen, PO | 2 |
| Truss, MC | 2 |
| Becker, AJ | 2 |
| Djamilian, MH | 1 |
| Fontana, D | 1 |
| Rolle, L | 1 |
| Del Noce, G | 1 |
| Tamagnone, A | 1 |
| Rosso, C | 1 |
| Valdevenito, R | 1 |
| Melman, A | 1 |
| Jung, A | 1 |
| Schill, WB | 1 |
| Lin, JS | 1 |
| Chang, WC | 1 |
| Lui, SM | 1 |
| Zucconi, M | 1 |
| Pozza, G | 2 |
| Armstrong, DK | 1 |
| Convery, AG | 1 |
| Chao, R | 1 |
| Clowers, DE | 1 |
| Govier, FE | 1 |
| McClure, RD | 1 |
| Weissman, RM | 1 |
| Gibbons, RP | 1 |
| Pritchett, TR | 1 |
| Kramer-Levien, D | 2 |
| Kim, SC | 4 |
| Seo, KK | 4 |
| Oh, CH | 1 |
| Katlowitz, N | 1 |
| Albano, GJ | 2 |
| Patsias, G | 1 |
| Golimbu, M | 2 |
| Morales, P | 2 |
| Pastorini, S | 2 |
| Marino, G | 1 |
| Cocimano, V | 2 |
| Griffa, D | 1 |
| Pugno, E | 2 |
| Thon, WF | 3 |
| Hartmann, U | 3 |
| Djamilian, M | 2 |
| Freymann, H | 1 |
| Krah, H | 1 |
| Schlik, R | 1 |
| Jonas, J | 1 |
| Derouet, H | 3 |
| Zehl, U | 1 |
| Moriel, EZ | 1 |
| Rajfer, J | 1 |
| Schild, HH | 1 |
| Müller, SC | 1 |
| Hermann, M | 1 |
| Kaltenborn, H | 1 |
| Kern, M | 1 |
| Werner, W | 2 |
| Schubert, J | 2 |
| Navío, S | 1 |
| Allona, A | 1 |
| Serrano, A | 1 |
| Vallejo, J | 1 |
| del Hoyo, J | 1 |
| Rivas, JA | 1 |
| Escudero, A | 1 |
| von Heyden, B | 1 |
| Donatucci, CF | 1 |
| Kaula, N | 1 |
| Lue, TF | 3 |
| Katlowitz, NM | 1 |
| Kaufman, JM | 1 |
| Borges, FD | 1 |
| Fitch, WP | 1 |
| Geller, RA | 1 |
| Gruber, MB | 1 |
| Hubbard, JG | 1 |
| McKay, DL | 1 |
| Tuttle, JP | 1 |
| Witten, FR | 1 |
| Brandstetter, K | 1 |
| Schwarzer, JU | 1 |
| Bautz, W | 1 |
| Pickl, U | 1 |
| Lenz, M | 1 |
| McLoughlin, J | 1 |
| Asopa, R | 1 |
| Williams, G | 11 |
| Bechara, A | 3 |
| Casabé, A | 3 |
| Chéliz, G | 2 |
| Romano, S | 2 |
| Fredotovich, N | 2 |
| Marten Perolino, R | 1 |
| Millard, RJ | 1 |
| Stricker, PD | 1 |
| Lynch, WJ | 1 |
| Dean, TE | 1 |
| Murnaghan, GF | 1 |
| Breslin, FH | 1 |
| Purvis, K | 2 |
| Brekke, I | 1 |
| Christiansen, E | 2 |
| de la Fuente, RB | 1 |
| Bossinger, W | 1 |
| Sasso, F | 2 |
| Gulino, G | 2 |
| Alcini, A | 1 |
| Alcini, E | 2 |
| Flynn, RJ | 1 |
| Salinas Casado, J | 2 |
| Vírseda Chamorro, M | 2 |
| Samblas García, R | 2 |
| Esteban Fuertes, M | 2 |
| Aristizábal Agudelo, JM | 2 |
| Blázquez Izquierdo, J | 2 |
| Delgado Martín, JA | 2 |
| Resel Estévez, L | 2 |
| Giuliano, F | 1 |
| Sundaram, CP | 1 |
| Thomas, W | 1 |
| Pryor, LE | 1 |
| Sidi, AA | 4 |
| Billups, K | 1 |
| Pryor, JL | 1 |
| Soderdahl, DW | 1 |
| Thrasher, JB | 1 |
| Hansberry, KL | 1 |
| Vicari, E | 1 |
| Calogero, AE | 1 |
| Miano, P | 1 |
| D'Agata, R | 1 |
| Reis, JM | 1 |
| Sogari, PR | 1 |
| Telöken, C | 1 |
| Souto, CA | 1 |
| Machtens, S | 1 |
| Alderdice, DK | 1 |
| Rey, H | 1 |
| de Meyer, JM | 2 |
| Thibo, P | 1 |
| Rodrigues, M | 1 |
| Granegger, S | 1 |
| O'Grady, J | 1 |
| Sinzinger, H | 1 |
| Stackl, W | 1 |
| Wunderlich, H | 1 |
| Fazeli-Matin, S | 1 |
| Angermeier, KW | 1 |
| Gingell, JC | 2 |
| Smith, EM | 1 |
| Netto, IC | 3 |
| Gladden, KH | 1 |
| Chaudhuri, TK | 3 |
| Fink, S | 3 |
| Kolm, P | 1 |
| Engel, JD | 1 |
| McVary, KT | 1 |
| Lottman, PE | 1 |
| Hendriks, JC | 1 |
| Vruggink, PA | 1 |
| Soli, M | 1 |
| Bertaccini, A | 1 |
| Carparelli, F | 1 |
| Gotti, R | 1 |
| Cavrini, V | 1 |
| Andrisano, V | 1 |
| Martorana, G | 1 |
| Nolden, W | 1 |
| Jost, WH | 1 |
| Osterhage, J | 1 |
| Eckert, RE | 1 |
| Ziegler, M | 3 |
| Kaplan, SA | 1 |
| Reis, RB | 1 |
| Kohn, IJ | 1 |
| Shabsigh, R | 2 |
| Te, AE | 1 |
| Brown, SL | 1 |
| Haas, CA | 1 |
| Koehler, M | 1 |
| Bodner, DR | 6 |
| Seftel, AD | 1 |
| Sherif, T | 1 |
| Adbel-Gawad, T | 1 |
| Asaad, T | 1 |
| Abdallah, HM | 1 |
| Shmueli, J | 4 |
| Israilov, S | 4 |
| Segenreich, E | 4 |
| Baniel, J | 4 |
| Livne, P | 2 |
| Mills, RD | 1 |
| Sethia, KK | 1 |
| Sandhu, D | 1 |
| Curless, E | 1 |
| Dean, J | 1 |
| Liu, S | 1 |
| Savage, D | 1 |
| Oakes, R | 1 |
| Frentz, G | 1 |
| Ioannidis, E | 1 |
| Kalinderis, A | 1 |
| Egdetveit, I | 1 |
| Samali, R | 1 |
| Johnson, H | 1 |
| Favre, M | 1 |
| Enria, T | 1 |
| Shcheplev, PA | 1 |
| Nesterov, SN | 1 |
| Kukharkin, SA | 1 |
| Abdullaev, IA | 1 |
| Sidorov, DV | 1 |
| Lee, SK | 1 |
| Song, ES | 1 |
| Lee, MY | 2 |
| Moncada Iribarren, I | 1 |
| Stolk, EA | 1 |
| Busschbach, JJ | 1 |
| Caffa, M | 1 |
| Rutten, FF | 1 |
| Andrade, JR | 1 |
| Traboulsi, A | 1 |
| Hussain, A | 1 |
| Dubin, NH | 1 |
| Andersson, K | 1 |
| Simon, D | 1 |
| Aversa, A | 1 |
| Bonifacio, V | 1 |
| Moretti, C | 1 |
| Frajese, G | 1 |
| Fabbri, A | 1 |
| Engelstein, D | 2 |
| Livne, PM | 2 |
| Silingardi, V | 1 |
| Galeazzi, GM | 1 |
| Rigatelli, M | 1 |
| Ranzi, A | 1 |
| Artibani, W | 1 |
| Porst, HC | 1 |
| Park, BD | 1 |
| Fu, Q | 1 |
| Yao, DH | 1 |
| Jiang, YQ | 1 |
| Holmes, S | 1 |
| Carson, C | 1 |
| Rosen, R | 1 |
| Islam, A | 1 |
| Ledda, A | 1 |
| de Boer, BJ | 1 |
| Kleinjans, HA | 1 |
| Leungwattanakij, S | 1 |
| Flynn, V | 1 |
| Hellstrom, WJ | 1 |
| Ribé, N | 1 |
| Rajmil, O | 1 |
| Bassas, L | 1 |
| Jurado, C | 1 |
| Pomerol, JM | 1 |
| Bleumer, I | 1 |
| Diemont, WL | 1 |
| van der Maas, MC | 1 |
| Claro, Jde A | 1 |
| de Aboim, JE | 1 |
| Maríngolo, M | 1 |
| Andrade, E | 1 |
| Aguiar, W | 1 |
| Nogueira, M | 1 |
| Nardozza Júnior, A | 1 |
| Srougi, M | 1 |
| Richter, S | 2 |
| Ringel, A | 1 |
| Shalev, M | 2 |
| Nissenkorn, I | 2 |
| Keijzers, GB | 1 |
| Jun, IO | 1 |
| Oh, MM | 1 |
| Beal, K | 1 |
| Mears, JG | 1 |
| Elhanbly, S | 1 |
| Schoor, R | 1 |
| Elmogy, M | 1 |
| Ross, L | 1 |
| Hegazy, A | 1 |
| Niederberger, C | 1 |
| Lee, KL | 1 |
| Kouvelas, D | 1 |
| Niv, E | 1 |
| Lammers, PI | 1 |
| Rubio-Aurioles, E | 1 |
| Castell, R | 1 |
| Castaneda, J | 1 |
| Ponce de Leon, R | 1 |
| Hurley, D | 1 |
| Lipezker, M | 1 |
| Loehr, LA | 1 |
| Lowrey, F | 1 |
| van der Windt, F | 1 |
| Dohle, GR | 1 |
| van der Tak, J | 1 |
| Slob, AK | 1 |
| Carson, CC | 2 |
| Lenk, S | 2 |
| Turner, LA | 7 |
| Althof, SE | 8 |
| Kanellos, A | 1 |
| Allen, RP | 2 |
| Engel, RM | 1 |
| Smolev, JK | 1 |
| Brendler, CB | 2 |
| Belgrano, E | 1 |
| Trombetta, C | 1 |
| Siracusano, S | 1 |
| Deriu, M | 1 |
| Salisci, E | 1 |
| Bellorofonte, C | 2 |
| Dell'Acqua, S | 2 |
| Ruoppolo, M | 2 |
| Zaatar, C | 2 |
| Tombolini, P | 2 |
| Wizenberg, P | 1 |
| D'Osvaldo, C | 1 |
| Rovegno, A | 1 |
| Fernández, H | 1 |
| Mocellini Iturralde, J | 1 |
| Morales Concepción, JC | 1 |
| Löbelenz, M | 1 |
| Jünemann, KP | 3 |
| Köhrmann, KU | 1 |
| Seemann, O | 1 |
| Rassweiler, J | 1 |
| Tschada, R | 1 |
| Alken, P | 1 |
| Levine, SB | 7 |
| Bodner, D | 4 |
| Kursh, ED | 7 |
| Resnick, MI | 6 |
| Gall, H | 10 |
| Bähren, W | 13 |
| Scherb, W | 10 |
| Holzki, G | 4 |
| Irion, R | 1 |
| Gerstenberg, TC | 1 |
| Metz, P | 1 |
| Ottesen, B | 1 |
| Fahrenkrug, J | 1 |
| Hollander, JB | 1 |
| Gonzalez, J | 1 |
| Norman, T | 1 |
| Leffler, B | 1 |
| Frost, F | 1 |
| Bemelmans, BL | 1 |
| Doesburg, WH | 1 |
| van Asten, WN | 1 |
| Skotnicki, SH | 1 |
| Debruyne, FM | 1 |
| Bell, DS | 1 |
| Cutter, GR | 1 |
| Hayne, VB | 1 |
| Lloyd, LK | 2 |
| Chandeck Montesa, K | 1 |
| Chen Jiménez, J | 1 |
| Tamayo, JC | 1 |
| Rodríguez Antolín, A | 1 |
| Alvarez González, E | 1 |
| Keogh, EJ | 4 |
| Ker, JK | 1 |
| Cherry, DJ | 1 |
| Tulloch, AG | 3 |
| Lord, DJ | 4 |
| Bouchot, O | 1 |
| Bondil, P | 1 |
| Navratil, H | 1 |
| Fein, RL | 1 |
| Davis, BE | 1 |
| Weigel, JW | 1 |
| Whitford, CS | 1 |
| Weiss, JN | 1 |
| Ravalli, R | 1 |
| Badlani, GH | 2 |
| Bennett, AH | 2 |
| Carpenter, AJ | 1 |
| Barada, JH | 1 |
| Elgammal, M | 1 |
| Gafir, S | 1 |
| Stein, L | 1 |
| Elhilali, M | 1 |
| Siegal, YI | 1 |
| Lindner, A | 1 |
| Caspari, D | 1 |
| Münch, M | 1 |
| Lidgi, S | 1 |
| Moskovitz, B | 1 |
| Levin, RD | 1 |
| Strohmaier, WL | 1 |
| Thomas, C | 1 |
| Wilbert, DM | 1 |
| Bichler, KH | 1 |
| Claussen, CD | 1 |
| Ferri, PM | 1 |
| Yamak, R | 1 |
| Tagliaferri, A | 1 |
| Török, A | 1 |
| Jilling, A | 1 |
| Götz, F | 1 |
| Lowe, MA | 1 |
| Schwartz, AN | 1 |
| Berger, RE | 1 |
| Stricker, P | 1 |
| Wetterauer, U | 6 |
| Schaebsdau, FH | 1 |
| Kerfoot, WW | 1 |
| Risen, CB | 2 |
| Treiber, U | 1 |
| Helmy, AM | 1 |
| Pierce, LJ | 1 |
| Whittington, R | 1 |
| Hanno, PM | 1 |
| English, W | 1 |
| Wein, AJ | 1 |
| Goodman, RL | 1 |
| Fishman, IJ | 1 |
| Toombs, BD | 1 |
| Skolkin, M | 1 |
| Floth, A | 2 |
| Schramek, P | 3 |
| VanderBurg Mendendorp, S | 1 |
| Tesar, LJ | 1 |
| Kaplan, HS | 1 |
| Schönherr, G | 1 |
| Korner, I | 1 |
| Drawz, G | 1 |
| Drawz, B | 1 |
| Seemann, B | 1 |
| Heydel, E | 1 |
| Schultz, J | 1 |
| Heydenreich, A | 1 |
| Kmietzyk, HJ | 1 |
| Hasse, N | 1 |
| Bast, R | 1 |
| Eilitz, B | 1 |
| Weiske, WH | 4 |
| Kulvelis, F | 1 |
| Popken, G | 1 |
| Staubesand, J | 1 |
| Sommerkamp, H | 2 |
| VanderBrug Medendorp, S | 1 |
| Tesar, L | 1 |
| Schover, LR | 1 |
| Fried, FA | 1 |
| Papadopoulos, I | 1 |
| Weichert-Jacobsen, K | 1 |
| Wand, H | 1 |
| Cameron, JS | 2 |
| Duffy, LM | 1 |
| Lange, PH | 2 |
| Gallwitz, A | 2 |
| Altwein, JE | 6 |
| Gilbert, P | 2 |
| Wetterhauer, U | 1 |
| Thon, W | 4 |
| Beckert, R | 4 |
| Trapp, JD | 1 |
| Kiely, EA | 6 |
| Blank, MA | 1 |
| Bloom, SR | 2 |
| Nellans, RE | 1 |
| Ellis, LR | 1 |
| Hu, KN | 1 |
| Burks, C | 1 |
| Christy, WC | 1 |
| Dykstra, DD | 1 |
| Reinberg, Y | 1 |
| Risen, C | 3 |
| Resnick, M | 2 |
| Weinberg, JJ | 1 |
| Asakawa, M | 1 |
| Kawashima, H | 1 |
| Yoshimura, R | 1 |
| Maekawa, T | 1 |
| Kashiwara, N | 1 |
| Tanaka, H | 1 |
| Nishio, S | 1 |
| Hadzija, BW | 1 |
| Mattocks, AM | 1 |
| Stahl, GM | 1 |
| Wang, ZR | 1 |
| Nelson, RP | 1 |
| Nakajima, Y | 1 |
| Shibayama, T | 1 |
| Yamamoto, H | 1 |
| Suzuki, Y | 1 |
| Matsuoka, K | 1 |
| Kaneda, S | 1 |
| Kirkeby, HJ | 1 |
| Forman, A | 1 |
| Sørensen, S | 1 |
| Andersson, KE | 1 |
| Lefleur, RS | 1 |
| Richards, JS | 1 |
| Sparwasser, CH | 1 |
| Martin-du Pan, R | 1 |
| Zentgraf, M | 3 |
| Ludwig, G | 2 |
| Burger, RH | 1 |
| Palmer, JD | 1 |
| Watters, GR | 3 |
| Carati, CJ | 3 |
| Tulloch, GS | 1 |
| Keuler, F | 1 |
| Rudnick, J | 1 |
| Pauthner, H | 1 |
| Weidner, W | 1 |
| Shantha, TR | 1 |
| Finnerty, DP | 1 |
| Rodriquez, AP | 1 |
| Seidmon, EJ | 1 |
| Samaha, AM | 1 |
| Kursh, E | 1 |
| Garofalo, FA | 1 |
| Blum, MD | 1 |
| Bahnson, RR | 1 |
| Porter, TN | 1 |
| Carter, MF | 1 |
| Schneider, AW | 1 |
| Busch, R | 1 |
| Gonnermann, D | 1 |
| Klosterhalfen, H | 1 |
| Lee, LM | 1 |
| Stevenson, RW | 2 |
| Szasz, G | 2 |
| van Ahlen, H | 1 |
| Holzmann, RM | 1 |
| Waldhauser, M | 1 |
| Turner, L | 1 |
| Mulcahy, MJ | 2 |
| Desai, KM | 1 |
| Bookstein, JJ | 3 |
| Fellmeth, B | 1 |
| Moreland, S | 1 |
| Lurie, AL | 1 |
| Payton, T | 1 |
| Benson, GS | 1 |
| Seifert, WE | 1 |
| Girdley, FM | 1 |
| Bruskewitz, RC | 3 |
| Feyzi, J | 1 |
| Graversen, PH | 1 |
| Gasser, TC | 3 |
| Marmar, JL | 1 |
| DeBenedictis, TJ | 1 |
| Praiss, DE | 1 |
| Ruutu, M | 1 |
| Lindström, BL | 1 |
| Virtanen, J | 1 |
| Alfthan, O | 1 |
| Hartnell, G | 1 |
| Kiely, E | 1 |
| Rousseau, P | 1 |
| Jecht, E | 1 |
| Müller-Mattheis, V | 1 |
| Baccouche, M | 2 |
| Lühmann, R | 1 |
| Dennis, RL | 2 |
| McDougal, WS | 1 |
| Goldstein, M | 1 |
| Brosman, S | 1 |
| Steffens, J | 1 |
| Postma, HJ | 1 |
| Steffens, L | 1 |
| Wehnert, J | 1 |
| Kramer, J | 1 |
| Weller, J | 1 |
| Leike, S | 1 |
| Ferrière, JM | 1 |
| Gaston, R | 1 |
| Piechaud, T | 1 |
| Le Guillou, M | 1 |
| Gwinup, G | 1 |
| Sanfelippo, CJ | 1 |
| Deason, AM | 1 |
| Tully, AJ | 1 |
| Leitner, WA | 1 |
| Spivey, C | 1 |
| Morgan, C | 1 |
| Holmes, B | 1 |
| Russell, RT | 1 |
| Gilling, PJ | 1 |
| Wright, WL | 1 |
| Gray, JM | 1 |
| Meyer, JJ | 1 |
| Pettirossi, O | 1 |
| Serenelli, G | 1 |
| Quadraccia, A | 1 |
| Salvini, A | 1 |
| Cordani, C | 1 |
| Pizzi, P | 1 |
| Bellinzoni, G | 1 |
| Janosko, EO | 1 |
| Nankin, HR | 1 |
| Osterman, J | 1 |
| Lin, T | 1 |
| Snoddy, W | 1 |
| Roach, RM | 1 |
| Larsen, EH | 2 |
| Tanagho, EA | 1 |
| Valji, K | 1 |
| Parsons, L | 1 |
| Kessler, W | 1 |
| Lee, M | 1 |
| Sharifi, R | 1 |
| Baum, N | 1 |
| Puyau, FA | 1 |
| Lewis, RW | 1 |
| Balkin, P | 1 |
| Kaack, MB | 1 |
| Hirsch, A | 1 |
| Ignotus, P | 1 |
| Lindan, R | 1 |
| Leffler, E | 1 |
| Al-Juburi, AZ | 1 |
| O'Donnell, PD | 1 |
| Lee, L | 1 |
| Sanders, HD | 1 |
| Wyndaele, JJ | 1 |
| de Sy, WA | 1 |
| Claessens, H | 1 |
| Krane, RJ | 1 |
| Robinette, MA | 1 |
| Moffat, MJ | 1 |
| Goldie, L | 1 |
| Cameron, L | 1 |
| Woodruff, P | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Influence of Treatment With the HMG-CoA-Reductase Inhibitor Fluvastatin on Erectile Function in Patients With Cardiovascular Risk-Factors and Erectile Dysfunction[NCT00382161] | Phase 3 | 20 participants (Anticipated) | Interventional | 2006-10-31 | Withdrawn (stopped due to not enough patients meeting inclusion criteria) | ||
| Sirolimus Eluting Balloon Utilization for Treatment of Vasculogenic Erectile Dysfunction - The SUASION Study[NCT04345965] | 100 participants (Anticipated) | Observational | 2019-09-01 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
42 reviews available for phentolamine and Erectile Dysfunction
| Article | Year |
|---|---|
Erectile dysfunction: a global review of intracavernosal injectables.
Topics: Alprostadil; Drug Combinations; Erectile Dysfunction; Humans; Injections, Intralesional; Male; Penis | 2019 |
Future directions in erectile dysfunction therapy.
Topics: Adrenergic alpha-Antagonists; Apomorphine; Clinical Trials as Topic; Dopamine Agonists; Erectile Dys | 2000 |
Pharmacological aspects of erectile dysfunction.
Topics: Adult; Aged; Alprostadil; Apomorphine; Drug Interactions; Erectile Dysfunction; Humans; Male; Middle | 2002 |
[Catecholamine].
Topics: Adrenergic alpha-Antagonists; Catecholamines; Erectile Dysfunction; Humans; Male; Muscle, Smooth; No | 2002 |
Erectile dysfunction: oral pharmacotherapy options.
Topics: Administration, Oral; Adult; Erectile Dysfunction; Humans; Imidazoles; Intestinal Absorption; Male; | 2002 |
Pharmacological management of erectile dysfunction.
Topics: Administration, Oral; Adrenergic alpha-Antagonists; Alprostadil; Apomorphine; Carbolines; Drug Combi | 2003 |
The etiology of erectile dysfunction and mechanisms by which drugs improve erection.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Apomorphine; Erectile Dysfunction; Humans | 2003 |
A comparative review of the options for treatment of erectile dysfunction: which treatment for which patient?
Topics: Administration, Oral; Alprostadil; Apomorphine; Carbolines; Constriction; Contraindications; Dopamin | 2005 |
Available and future treatments for erectile dysfunction.
Topics: Apomorphine; Erectile Dysfunction; Humans; Male; Phentolamine; Phosphodiesterase Inhibitors; Testost | 2005 |
Diagnosing erectile dysfunction: instruments for the study of smooth muscle relaxation.
Topics: Erectile Dysfunction; Hemodynamics; Humans; Male; Muscle Relaxation; Muscle Tonus; Muscle, Smooth; P | 2005 |
Vasoactive intestinal polypeptide/phentolamine for intracavernosal injection in erectile dysfunction.
Topics: Aged; Drug Combinations; Erectile Dysfunction; Humans; Injections; Male; Middle Aged; Patient Satisf | 2008 |
[Diagnosis and therapy of erectile dysfunction].
Topics: Diagnosis, Differential; Erectile Dysfunction; Humans; Male; Papaverine; Patient Care Team; Penile E | 1993 |
Intracavernous pharmacotherapy for impotence: selection of appropriate agent and dose.
Topics: Adult; Aged; Aged, 80 and over; Alprostadil; Arteries; Drug Therapy, Combination; Erectile Dysfuncti | 1993 |
Pharmacological management of erectile dysfunction.
Topics: Administration, Oral; Erectile Dysfunction; Humans; Injections, Intravenous; Male; Nitroglycerin; Pa | 1995 |
[Treatment per os of disorders of erection].
Topics: Administration, Oral; Adrenergic alpha-Antagonists; Antidepressive Agents, Second-Generation; Apomor | 1997 |
New developments in self-injection therapy for erectile dysfunction.
Topics: Alprostadil; Calcitonin Gene-Related Peptide; Chlorpromazine; Dose-Response Relationship, Drug; Erec | 1998 |
[Pharmacotherapy of erectile dysfunction].
Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Adrenergic alpha-Antagonists; Alprostadil; Drug Therapy, Combin | 1999 |
Pharmacological treatment of erectile dysfunction.
Topics: Adrenergic alpha-Antagonists; Alprostadil; Apomorphine; Dopamine Agonists; Erectile Dysfunction; Hum | 1999 |
[Oral therapy of erectile dysfunction].
Topics: Administration, Oral; Adrenergic alpha-Antagonists; Adult; Apomorphine; Dopamine Agonists; Erectile | 2000 |
Oral phentolamine: an alpha-1, alpha-2 adrenergic antagonist for the treatment of erectile dysfunction.
Topics: Administration, Oral; Adrenergic alpha-Antagonists; Clinical Trials, Phase III as Topic; Erectile Dy | 2000 |
Penile erection and cardiac risk: pathophysiologic and pharmacologic mechanisms.
Topics: Adrenergic alpha-Antagonists; Animals; Coronary Disease; Erectile Dysfunction; Heart; Humans; Male; | 2000 |
Treatment of male sexual dysfunction.
Topics: Adrenergic alpha-Antagonists; Adult; Clomipramine; Ejaculation; Erectile Dysfunction; Hormone Replac | 2000 |
Erectile dysfunction: intracavernous treatment.
Topics: Adrenergic alpha-Antagonists; Alprostadil; Erectile Dysfunction; Humans; Injections; Male; Papaverin | 2000 |
Intracavernosal injection and intraurethral therapy for erectile dysfunction.
Topics: Adrenergic alpha-Antagonists; Drug Therapy, Combination; Erectile Dysfunction; Humans; Male; Papaver | 2001 |
Aviptadil (Senatek).
Topics: Clinical Trials as Topic; Drug Combinations; Erectile Dysfunction; Humans; Male; Phentolamine; Vasoa | 2001 |
Pharmacotherapy for erectile dysfunction.
Topics: Alprostadil; Erectile Dysfunction; Humans; Male; Nitric Oxide Donors; Papaverine; Phentolamine; Pipe | 2000 |
Oral and injectable medications for the treatment of erectile dysfunction.
Topics: Administration, Oral; Administration, Topical; Erectile Dysfunction; Humans; Injections; Male; Penil | 2000 |
The management of erectile dysfunction following spinal cord injury.
Topics: Alprostadil; Autonomic Nervous System; Erectile Dysfunction; Follow-Up Studies; Humans; Male; Penile | 1992 |
[Prospective study of the effectiveness and side effects of intracavernous prostaglandin E1 versus papaverine or papaverine phentolamine in the diagnosis and treatment of erection dysfunction. Review of the literature].
Topics: Adult; Alprostadil; Erectile Dysfunction; Humans; Male; Middle Aged; Papaverine; Phentolamine; Prosp | 1992 |
[A year in male impotence].
Topics: Age Factors; Alprostadil; Animals; Castration; Clinical Trials as Topic; Disease Models, Animal; Dog | 1991 |
[Intracavernous injections for the treatment of erectile dysfunction].
Topics: Erectile Dysfunction; Humans; Injections; Male; Papaverine; Penile Erection; Phentolamine | 1991 |
[Endocavernous drug infusions revisited].
Topics: Alprostadil; Erectile Dysfunction; Humans; Injections; Ketanserin; Male; Papaverine; Penile Erection | 1991 |
Erectile dysfunction-advances.
Topics: Erectile Dysfunction; Humans; Injections; Male; Papaverine; Penile Erection; Penile Prosthesis; Phen | 1991 |
[Current diagnosis of impotence].
Topics: Adult; Aged; Blood Pressure; Diagnosis, Differential; Erectile Dysfunction; Humans; Male; Middle Age | 1990 |
Vasoactive intracavernous pharmacotherapy.
Topics: Dose-Response Relationship, Drug; Drug Therapy, Combination; Erectile Dysfunction; Follow-Up Studies | 1988 |
[Efficacy of intracavernous injection of papaverine and prostaglandin in the diagnosis and treatment of erectile impotence].
Topics: Erectile Dysfunction; Humans; Injections; Male; Papaverine; Penile Erection; Penis; Phentolamine; Pr | 1989 |
How safe is the treatment of impotence with intracavernous autoinjection?
Topics: Drug Combinations; Erectile Dysfunction; Fibrosis; Humans; Male; Papaverine; Penile Erection; Penis; | 1989 |
Physiological considerations in radionuclide imaging of the penis during impotence therapy.
Topics: Drug Combinations; Erectile Dysfunction; Erythrocytes; Humans; Male; Papaverine; Penile Erection; Pe | 1989 |
[Diagnosis of erectile impotence].
Topics: Erectile Dysfunction; Humans; Male; Papaverine; Penile Erection; Penis; Phentolamine; Regional Blood | 1989 |
Injection therapy for impotence.
Topics: Clinical Trials as Topic; Drug Administration Schedule; Drug Therapy, Combination; Erectile Dysfunct | 1988 |
Impotence in elderly men.
Topics: Aged; Aging; Erectile Dysfunction; Humans; Male; Papaverine; Penis; Phentolamine; Physical Examinati | 1988 |
Diagnosis and therapy of erectile dysfunction using papaverine and phentolamine.
Topics: Drug Therapy, Combination; Erectile Dysfunction; Humans; Male; Papaverine; Penile Erection; Phentola | 1988 |
54 trials available for phentolamine and Erectile Dysfunction
| Article | Year |
|---|---|
Long-term safety and efficacy of oral phentolamine mesylate (Vasomax) in men with mild to moderate erectile dysfunction.
Topics: Administration, Oral; Adrenergic alpha-Antagonists; Adult; Aged; Aged, 80 and over; Erectile Dysfunc | 2002 |
Comparison of the efficacy and safety of sildenafil citrate (Viagra) and oral phentolamine for the treatment of erectile dysfunction.
Topics: Administration, Oral; Adolescent; Adrenergic alpha-Antagonists; Adult; Aged; Aged, 80 and over; Coit | 2002 |
[Comparing effect in the management of erectile dysfunction by using 2 sets of drugs of intracavernosal injection].
Topics: Adult; Erectile Dysfunction; Humans; Injections; Male; Middle Aged; Papaverine; Phentolamine; Pyrazi | 2003 |
[Assessment of curative effect on erectile dysfunction of two drugs].
Topics: Adrenergic alpha-Antagonists; Double-Blind Method; Erectile Dysfunction; Humans; Male; Phentolamine; | 2003 |
The value of penile duplex in the prediction of intracavernous drug-induced priapism.
Topics: Alprostadil; Antihypertensive Agents; Erectile Dysfunction; Humans; Ischemia; Male; Middle Aged; Pap | 2004 |
Clinical and sonographic assessment of the side effects of intracavernous injection of vasoactive substances.
Topics: Adult; Alprostadil; Drug Combinations; Erectile Dysfunction; Fibrosis; Humans; Injections, Intralesi | 2004 |
Intracavernous sodium nitroprusside (SNP) versus papaverine/phentolamine in erectile dysfunction: a comparative study of short-term efficacy and side-effects.
Topics: Adrenergic alpha-Antagonists; Adult; Drug Therapy, Combination; Erectile Dysfunction; Humans; Inject | 2005 |
Intracavernous chlorpromazine versus phentolamine: a double-blind clinical comparative study.
Topics: Adrenergic alpha-Antagonists; Chlorpromazine; Double-Blind Method; Drug Administration Routes; Drug | 2004 |
Injection therapy for the treatment of erectile dysfunction: a comparison between alprostadil and a combination of vasoactive intestinal polypeptide and phentolamine mesilate.
Topics: Adult; Aged; Alprostadil; Cross-Over Studies; Drug Therapy, Combination; Erectile Dysfunction; Human | 2007 |
Experience with buccal phentolamine mesylate for impotence.
Topics: Administration, Buccal; Erectile Dysfunction; Humans; Male; Middle Aged; Penis; Phenoxybenzamine; Ph | 1994 |
Papaverine-phentolamine and prostaglandin E1 versus papaverine-phentolamine alone for intracorporeal injection therapy: a clinical double-blind study.
Topics: Adult; Aged; Alprostadil; Double-Blind Method; Drug Combinations; Erectile Dysfunction; Humans; Impo | 1995 |
Comparison of a mixture of papaverine, phentolamine and prostaglandin E1 with other intracavernous injections.
Topics: Alprostadil; Drug Combinations; Erectile Dysfunction; Fibrosis; Follow-Up Studies; Humans; Injection | 1994 |
Long-term results of therapy with intracavernousal injections and penile venous surgery in chronic erectile dysfunction.
Topics: Adult; Age Factors; Chronic Disease; Drug Combinations; Erectile Dysfunction; Humans; Impotence, Vas | 1994 |
Role of the nitric oxide donor linsidomine chlorhydrate (SIN-1) in the diagnosis and treatment of erectile dysfunction.
Topics: Adult; Aged; Drug Therapy, Combination; Electromyography; Erectile Dysfunction; Follow-Up Studies; H | 1994 |
Intracavernous self-injection pharmacotherapy program: analysis of results and complications.
Topics: Adult; Aged; Aged, 80 and over; Alprostadil; Drug Combinations; Erectile Dysfunction; Humans; Impote | 1994 |
Sodium bicarbonate alleviates penile pain induced by intracavernous injections for erectile dysfunction.
Topics: Adult; Aged; Alprostadil; Bicarbonates; Double-Blind Method; Drug Combinations; Erectile Dysfunction | 1993 |
[A program of intracavernous drug-induced erection for the treatment of impotence].
Topics: Administration, Topical; Dose-Response Relationship, Drug; Drug Evaluation; Ejaculatory Ducts; Erect | 1993 |
Intracavernous pharmacotherapy for impotence: selection of appropriate agent and dose.
Topics: Adult; Aged; Aged, 80 and over; Alprostadil; Arteries; Drug Therapy, Combination; Erectile Dysfuncti | 1993 |
Prostaglandin E1 versus mixture of prostaglandin E1, papaverine and phentolamine in nonresponders to high papaverine plus phentolamine doses.
Topics: Adult; Aged; Alprostadil; Drug Therapy, Combination; Erectile Dysfunction; Humans; Male; Middle Aged | 1996 |
Determinants of satisfactory rigidity after intracavernosal injection with prostaglandin E1 in men with erectile failure.
Topics: Adrenergic alpha-Antagonists; Aging; Alprostadil; Drug Combinations; Erectile Dysfunction; Gonadal S | 1996 |
Prostaglandin E1 with phentolamine for the treatment of erectile dysfunction.
Topics: Adrenergic alpha-Antagonists; Adult; Aged; Alprostadil; Drug Combinations; Erectile Dysfunction; Hum | 1996 |
Intracavernosal drug-induced erection therapy versus external vacuum devices in the treatment of erectile dysfunction.
Topics: Adult; Aged; Aged, 80 and over; Alprostadil; Attitude to Health; Coitus; Cross-Over Studies; Erectil | 1997 |
Atropine role in the pharmacological erection test: study of 228 patients.
Topics: Adult; Aged; Alprostadil; Atropine; Drug Therapy, Combination; Erectile Dysfunction; Humans; Male; M | 1997 |
Oral phentolamine as treatment for erectile dysfunction.
Topics: Administration, Oral; Adrenergic alpha-Antagonists; Adult; Aged; Double-Blind Method; Erectile Dysfu | 1998 |
Transurethral alprostadil as therapy for patients who withdrew from or failed prior intracavernous injection therapy.
Topics: Administration, Topical; Adrenergic alpha-Antagonists; Adult; Aged; Aged, 80 and over; Alprostadil; | 1998 |
Treatment of erectile dysfunction by an external ischiocavernous muscle stimulator.
Topics: Adult; Aged; Combined Modality Therapy; Electric Stimulation Therapy; Erectile Dysfunction; Humans; | 1998 |
Combination therapy using oral alpha-blockers and intracavernosal injection in men with erectile dysfunction.
Topics: Administration, Oral; Adrenergic alpha-Antagonists; Adult; Aged; Alprostadil; Doxazosin; Drug Therap | 1998 |
A double blind, placebo controlled study of intracavernosal vasoactive intestinal polypeptide and phenotolamine mesylate in a novel auto-injector for the treatment of non-psychogenic erectile dysfunction.
Topics: Adult; Aged; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Erectile Dys | 1999 |
Hemodynamic characterization of a functional erection. Arterial and corporeal veno-occlusive function in patients with a positive intracavernosal injection test.
Topics: Adult; Alprostadil; Constriction, Pathologic; Erectile Dysfunction; Hemodynamics; Humans; Impotence, | 1999 |
Treatment of intracorporeal injection nonresponse with sildenafil alone or in combination with triple agent intracorporeal injection therapy.
Topics: Adult; Aged; Alprostadil; Drug Therapy, Combination; Erectile Dysfunction; Humans; Injections; Middl | 1999 |
Re-dosing of prostaglandin-E1 versus prostaglandin-E1 plus phentolamine in male erectile dysfunction: a dynamic color power Doppler study.
Topics: Adrenergic alpha-Antagonists; Adult; Aged; Alprostadil; Arterioles; Case-Control Studies; Drug Combi | 2000 |
Three-year outcome of a progressive treatment program for erectile dysfunction with intracavernous injections of vasoactive drugs.
Topics: Adult; Aged; Aged, 80 and over; Alprostadil; Drug Therapy, Combination; Erectile Dysfunction; Follow | 2000 |
Audiovisual sexual stimulation by virtual glasses is effective in inducing complete cavernosal smooth muscle relaxation: a pharmacocavernosometric study.
Topics: Adult; Aged; Audiovisual Aids; Erectile Dysfunction; Eyeglasses; Humans; Male; Middle Aged; Muscle R | 2000 |
Risk factors for an early increase in dose of vasoactive agents for intracavernous pharmacotherapy.
Topics: Adult; Aged; Alprostadil; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Thera | 2000 |
A clinical comparative study on effects of intracavernous injection of sodium nitroprusside and papaverine/phentolamine in erectile dysfunction patients.
Topics: Adult; Aged; Drug Administration Routes; Drug Therapy, Combination; Erectile Dysfunction; Humans; Ma | 2000 |
[Response to intracavernous administration of 3 different drugs in the same group of patients with erectile dysfunction].
Topics: Adrenergic alpha-Antagonists; Alprostadil; Erectile Dysfunction; Humans; Injections; Male; Papaverin | 2001 |
Effects of oral phentolamine, taken before sleep, on nocturnal erectile activity: a double-blind, placebo-controlled, crossover study.
Topics: Administration, Oral; Adult; Circadian Rhythm; Cross-Over Studies; Double-Blind Method; Drug Adminis | 2001 |
Combination therapy for erectile dysfunction: a randomized, double blind, unblinded active-controlled, cross-over study of the pharmacodynamics and safety of combined oral formulations of apomorphine hydrochloride, phentolamine mesylate and papaverine hyd
Topics: Adrenergic alpha-Antagonists; Apomorphine; Cross-Over Studies; Double-Blind Method; Drug Combination | 2002 |
Intracavernosal injection therapy with and without sexological counselling in men with erectile dysfunction.
Topics: Adult; Aged; Attitude to Health; Coitus; Drug Therapy, Combination; Erectile Dysfunction; Humans; In | 2002 |
Objective double-blind evaluation of erectile function with intracorporeal papaverine in combination with phentolamine and/or prostaglandin E1.
Topics: Alprostadil; Double-Blind Method; Drug Therapy, Combination; Erectile Dysfunction; Humans; Male; Pap | 1992 |
[Prospective study of the effectiveness and side effects of intracavernous prostaglandin E1 versus papaverine or papaverine phentolamine in the diagnosis and treatment of erection dysfunction. Review of the literature].
Topics: Adult; Alprostadil; Erectile Dysfunction; Humans; Male; Middle Aged; Papaverine; Phentolamine; Prosp | 1992 |
Pharmacologic erection with intracavernosal injection for men with sexual dysfunction following irradiation: a preliminary report.
Topics: Adenoma; Aged; Erectile Dysfunction; Humans; Male; Middle Aged; Papaverine; Penile Erection; Phentol | 1991 |
Medical treatment of impotence with papaverine and phentolamine intracavernosal injection.
Topics: Adult; Aged; Erectile Dysfunction; Humans; Injections; Male; Middle Aged; Papaverine; Penis; Phentol | 1990 |
Intracavernous drug-induced erections in the management of male erectile dysfunction: experience with 100 patients.
Topics: Adult; Aged; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Combinations; Erectile | 1986 |
Vasoactive intracavernous pharmacotherapy for the treatment of erectile impotence in men with spinal cord injury.
Topics: Adult; Clinical Trials as Topic; Drug Combinations; Erectile Dysfunction; Follow-Up Studies; Humans; | 1987 |
Treatment of impotence by intrapenile injections. A comparison of papaverine versus papaverine and phentolamine: a double-blind, crossover trial.
Topics: Adult; Aged; Clinical Trials as Topic; Double-Blind Method; Drug Combinations; Erectile Dysfunction; | 1989 |
Effect of local alpha-adrenergic blockade on human penile erection.
Topics: Adrenergic alpha-Antagonists; Adult; Aged; Double-Blind Method; Erectile Dysfunction; Humans; Male; | 1985 |
Prostaglandin E1 versus phentolamine/papaverine for the treatment of erectile impotence: a double-blind comparison.
Topics: Alprostadil; Double-Blind Method; Drug Therapy, Combination; Erectile Dysfunction; Humans; Male; Pap | 1989 |
Efficiency and side effects of prostaglandin E1 in the treatment of erectile dysfunction.
Topics: Alprostadil; Clinical Trials as Topic; Double-Blind Method; Erectile Dysfunction; Humans; Male; Midd | 1988 |
Injection therapy for impotence.
Topics: Clinical Trials as Topic; Drug Administration Schedule; Drug Therapy, Combination; Erectile Dysfunct | 1988 |
[Open multicenter study of the differential diagnosis of erectile dysfunction with a papaverine-phentolamine combination (BY023)].
Topics: Adolescent; Adult; Aged; Clinical Trials as Topic; Diagnosis, Differential; Drug Combinations; Erect | 1988 |
Intracavernous self-injection with phentolamine and papaverine for the treatment of impotence.
Topics: Aged; Clinical Trials as Topic; Double-Blind Method; Erectile Dysfunction; Humans; Injections; Male; | 1987 |
Penile function following intracavernosal injection of vasoactive agents or saline.
Topics: Adult; Aged; Double-Blind Method; Drug Combinations; Erectile Dysfunction; Humans; Male; Middle Aged | 1987 |
Induction of penile erection by intracavernosal injection: a double-blind comparison of phenoxybenzamine versus papaverine-phentolamine versus saline.
Topics: Adult; Double-Blind Method; Drug Combinations; Erectile Dysfunction; Humans; Injections; Male; Middl | 1987 |
233 other studies available for phentolamine and Erectile Dysfunction
| Article | Year |
|---|---|
[Application value of Toshiba 320-row dynamic volumetric CT angiography in the diagnosis of venous erectile dysfunction].
Topics: Adult; Arteries; Computed Tomography Angiography; Contrast Media; Drug Combinations; Erectile Dysfun | 2016 |
Injection anxiety and pain in men using intracavernosal injection therapy after radical pelvic surgery.
Topics: Aged; Alprostadil; Anxiety; Drug Combinations; Erectile Dysfunction; Humans; Injections; Male; Middl | 2013 |
The role of intracavernosal injection therapy and the reasons of withdrawal from therapy in patients with erectile dysfunction in the era of PDE5 inhibitors.
Topics: Alprostadil; Coitus; Erectile Dysfunction; Humans; Injections; Male; Middle Aged; Papaverine; Patien | 2014 |
Male sexual dysfunction in unconsummated marriage: long-term outcome in 417 patients.
Topics: Adolescent; Adult; Aged; Clomipramine; Erectile Dysfunction; Female; Fluoxetine; Follow-Up Studies; | 2008 |
The anatomy of drug development: Invicorp, a product before its time.
Topics: Drug Combinations; Drug Design; Erectile Dysfunction; Humans; Male; Phentolamine; Phosphodiesterase | 2010 |
Rehabilitation of the cavernous smooth muscle in patients with organic erectile dysfunction.
Topics: Adult; Alprostadil; Arteries; Coitus; Constriction; Drug Combinations; Erectile Dysfunction; Humans; | 2012 |
Diagnostic steps in the evaluation of patients with erectile dysfunction.
Topics: Adult; Aged; Algorithms; Alprostadil; Diagnosis, Differential; Erectile Dysfunction; Humans; Impoten | 2002 |
[Current role of intracavernous therapy in the treatment of erectile dysfunction].
Topics: Adrenergic alpha-Antagonists; Alprostadil; Clinical Trials as Topic; Drug Combinations; Erectile Dys | 2002 |
Penile duplex pharmaco-ultrasonography revisited: revalidation of the parameters of the cavernous arterial response.
Topics: Adrenergic alpha-Antagonists; Adult; Aged; Arteries; Arteriosclerosis; Blood Flow Velocity; Carotid | 2003 |
Comparison of the relaxant effects of alfuzosin, phentolamine and sildenafil on rabbit isolated corpus cavernosum.
Topics: Adrenergic alpha-Antagonists; Animals; Erectile Dysfunction; Male; Muscle Relaxation; Penile Erectio | 2003 |
The incidence and management of priapism in Western Australia: a 16 year audit.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adult; Aged; Alprostadil; Drainage; Drug Co | 2003 |
Anxiety and high plasma catecholamines do not impair pharmaco-induced erection of psychogenic erectile dysfunctional patients.
Topics: Adrenergic alpha-Antagonists; Adult; Alprostadil; Anxiety; Drug Combinations; Epinephrine; Erectile | 2003 |
VASOSPASTIC REACTION TO METHYSERGIDE MALEATE SIMULATING LERICHE SYNDROME: INEFFECTIVE TREATMENT WITH ADRENERGIC BLOCKADE.
Topics: Adrenergic Agents; Cardiovascular Agents; Diagnosis, Differential; Drug Therapy; Erectile Dysfunctio | 1964 |
Long-term efficacy and compliance of intracorporeal (IC) injection for erectile dysfunction following radical prostatectomy: SHIM (IIEF-5) analysis.
Topics: Aged; Alprostadil; Antihypertensive Agents; Drug Therapy, Combination; Erectile Dysfunction; Follow- | 2003 |
Priapism associated with concurrent use of phosphodiesterase inhibitor drugs and intracavernous injection therapy.
Topics: Adult; Alprostadil; Drug Therapy, Combination; Erectile Dysfunction; Humans; Male; Middle Aged; Papa | 2003 |
Long-term intracavernous therapy responders can potentially switch to sildenafil citrate after radical prostatectomy.
Topics: Administration, Oral; Aged; Alprostadil; Erectile Dysfunction; Follow-Up Studies; Humans; Injections | 2004 |
Comparative effects of sildenafil, phentolamine, yohimbine and L-arginine on the rabbit corpus cavernosum.
Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Animals; Arginine; Atropine; Cyclic Nucleotide Phosphodiesteras | 2004 |
Methylene blue as a means of treatment for priapism caused by intracavernous injection to combat erectile dysfunction.
Topics: Enzyme Inhibitors; Erectile Dysfunction; Humans; Injections; Male; Methylene Blue; Papaverine; Phent | 2003 |
Cytotoxicity of different intracavernous vasoactive drugs on cultured endothelial cells of human corpus cavernosum penis.
Topics: Alprostadil; Cell Death; Cells, Cultured; Drug Interactions; Endothelial Cells; Endothelium, Vascula | 2004 |
Erectile dysfunction in spinal cord injury: a cost-utility analysis.
Topics: Adrenergic alpha-Antagonists; Adult; Aged; Alprostadil; Cost-Benefit Analysis; Drug Costs; Erectile | 2005 |
Intracavernous sodium nitroprusside (SNP) versus papaverine/phentolamine in erectile dysfunction: a comparative study of short-term efficacy and side-effects.
Topics: Drug Therapy, Combination; Erectile Dysfunction; Humans; Male; Nitroprusside; Papaverine; Phentolami | 2006 |
Different hemodynamic responses by color Doppler ultrasonography studies between sildenafil non-responders and responders.
Topics: Adult; Aged; Alprostadil; Erectile Dysfunction; Humans; Male; Middle Aged; Papaverine; Phentolamine; | 2007 |
Cavernosal alpha-blockade: a new technique for investigating and treating erectile impotence.
Topics: Adult; Erectile Dysfunction; Humans; Injections; Male; Middle Aged; Penis; Phenoxybenzamine; Phentol | 1983 |
Intracorporeal phenylephrine in the treatment of priapism.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Alprostadil; Blood Pressure; Erectile Dysfu | 1996 |
[Clinical evaluation of intracavernous self-injection of vasoactive drugs for impotence: a long-term follow-up observation].
Topics: Adult; Alprostadil; Erectile Dysfunction; Follow-Up Studies; Humans; Injections; Male; Middle Aged; | 1994 |
A positive intracavernous injection test implies normal veno-occlusive but not necessarily normal arterial function: a hemodynamic study.
Topics: Adolescent; Adult; Aged; Alprostadil; Arteries; Blood Pressure; Erectile Dysfunction; Humans; Inject | 1994 |
Four-drug intracavernous therapy for impotence due to corporeal veno-occlusive dysfunction.
Topics: Alprostadil; Atropine; Drug Administration Schedule; Drug Combinations; Erectile Dysfunction; Follow | 1993 |
Intracavernous vasoactive pharmacotherapy: the impact of a new self-injection device.
Topics: Alprostadil; Atropine; Drug Combinations; Equipment Design; Erectile Dysfunction; Humans; Injections | 1993 |
Effectiveness and safety of multidrug intracavernous therapy for vasculogenic impotence.
Topics: Alprostadil; Atropine; Drug Synergism; Drug Therapy, Combination; Erectile Dysfunction; Humans; Inje | 1993 |
The rationale for prostaglandin E1 (alpha-alprostadil) in the management of male impotence.
Topics: Alprostadil; Erectile Dysfunction; Humans; Impotence, Vasculogenic; Male; Molsidomine; Moxisylyte; P | 1995 |
Impotence following pelvic fracture urethral injury: incidence, aetiology and management.
Topics: Adolescent; Adult; Age Factors; Aged; Child; Erectile Dysfunction; Follow-Up Studies; Fractures, Bon | 1995 |
In vivo assessment of trabecular smooth muscle tone, its application in pharmaco-cavernosometry and analysis of intracavernous pressure determinants.
Topics: Adrenergic Agonists; Adult; Blood Flow Velocity; Blood Pressure; Erectile Dysfunction; Humans; Male; | 1995 |
Penile self-injection for impotence in patients after radical cystectomy.
Topics: Aged; Cystectomy; Erectile Dysfunction; Humans; Male; Middle Aged; Papaverine; Penile Erection; Phen | 1994 |
Love and sex after 60: how to evaluate and treat the impotent older man. A roundtable discussion: Part 2.
Topics: Aged; Alprostadil; Erectile Dysfunction; Female; Heart Diseases; Humans; Male; Middle Aged; Papaveri | 1994 |
[The pharmaco-erection test].
Topics: Alprostadil; Atropine; Diagnosis, Differential; Drug Combinations; Erectile Dysfunction; Humans; Imp | 1994 |
[Corpus cavernosum autoinjection therapy in erectile dysfunction?].
Topics: Dose-Response Relationship, Drug; Erectile Dysfunction; Humans; Impotence, Vasculogenic; Injections; | 1994 |
The change of penile blood thromboxane B2 and prostacyclin after intracavernous injection of vasoactive drugs for the treatment of arteriogenic impotence.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Aged; Alprostadil; Diabetes Complications; Epoprostenol; Erecti | 1994 |
Clinical reliability of multi-drug intracavernous vasoactive pharmacotherapy for diabetic impotence.
Topics: Adult; Aged; Alprostadil; Atropine; Diabetes Complications; Drug Combinations; Erectile Dysfunction; | 1994 |
Reasons for patient drop-out from an intracavernous auto-injection programme for erectile dysfunction.
Topics: Adult; Aged; Alprostadil; Erectile Dysfunction; Humans; Injections; Male; Middle Aged; Papaverine; P | 1994 |
Experience with intracavernosal tri-mixture for the management of neurogenic erectile dysfunction.
Topics: Adult; Alprostadil; Cost-Benefit Analysis; Drug Combinations; Drug Costs; Drug Monitoring; Drug Syne | 1994 |
Experience with triple-drug therapy in a pharmacological erection program.
Topics: Adult; Aged; Aged, 80 and over; Alprostadil; Cicatrix; Costs and Cost Analysis; Drug Combinations; E | 1993 |
Treatment of erectile dysfunction.
Topics: Alprostadil; Erectile Dysfunction; Humans; Injections; Male; Papaverine; Penile Erection; Penile Pro | 1993 |
Corporeal blood gas changes according to duration of drug-induced prolonged erection.
Topics: Adult; Carbon Dioxide; Erectile Dysfunction; Femoral Artery; Humans; Hydrogen-Ion Concentration; Mal | 1993 |
Effect of multidose intracorporeal injection and audiovisual sexual stimulation in vasculogenic impotence.
Topics: Alprostadil; Drug Therapy, Combination; Erectile Dysfunction; Humans; Male; Papaverine; Penile Erect | 1993 |
[Complications of intracavernous pharmacologic infusion in impotence. Long-term results].
Topics: Adult; Aged; Alprostadil; Drug Therapy, Combination; Erectile Dysfunction; Follow-Up Studies; Humans | 1993 |
[Effectiveness and safety of cavernous body auto-injection therapy with papaverine/phentolamine. Study group].
Topics: Adult; Aged; Drug Therapy, Combination; Ejaculation; Erectile Dysfunction; Humans; Injections, Intra | 1993 |
[Results of surgical therapy for venous insufficiency as a cause of erectile disorders].
Topics: Adult; Aged; Blood Flow Velocity; Erectile Dysfunction; Humans; Male; Middle Aged; Papaverine; Penis | 1993 |
[Treatment of erectile dysfunction with vacuum pumps].
Topics: Adult; Aged; Alprostadil; Combined Modality Therapy; Drug Therapy, Combination; Erectile Dysfunction | 1993 |
[Penile venous outflow occlusion: a comparison of erectile function and cavernosometry before and after percutaneous interventions].
Topics: Embolization, Therapeutic; Erectile Dysfunction; Humans; Male; Papaverine; Penile Erection; Penis; P | 1993 |
[Therapy of erectile dysfunction with corpus cavernosum autoinjection and current legal aspects].
Topics: Erectile Dysfunction; Humans; Male; Malpractice; Papaverine; Patient Education as Topic; Penile Erec | 1993 |
Predictive value of real-time RigiScan monitoring for the etiology of organogenic impotence.
Topics: Erectile Dysfunction; Humans; Injections; Male; Monitoring, Physiologic; Papaverine; Penile Erection | 1993 |
Potentiation of drug-induced erection with audiovisual sexual stimulation.
Topics: Alprostadil; Drug Combinations; Erectile Dysfunction; Erotica; Humans; Male; Middle Aged; Motion Pic | 1993 |
Evaluation of erectile dysfunction by dynamic infusion cavernosometry and cavernosography (DICC). Multi-institutional study.
Topics: Blood Pressure; Diabetic Angiopathies; Erectile Dysfunction; Humans; Male; Manometry; Middle Aged; P | 1993 |
[A comparison of color duplex sonography with selective penile DSA in assessing erectile dysfunction].
Topics: Adult; Aged; Angiography, Digital Subtraction; Color; Erectile Dysfunction; Evaluation Studies as To | 1993 |
Surgical treatment of venous leakage: medium-term follow-up.
Topics: Adult; Aged; Erectile Dysfunction; Follow-Up Studies; Humans; Ligation; Male; Middle Aged; Papaverin | 1993 |
[Topical treatment of erectile dysfunction. Possibilities and perspectives].
Topics: Administration, Cutaneous; Erectile Dysfunction; Humans; Male; Minoxidil; Papaverine; Phentolamine; | 1995 |
Risks of self-injection therapy for impotence.
Topics: Erectile Dysfunction; Humans; Male; Papaverine; Penile Erection; Phentolamine; Priapism; Self Admini | 1996 |
[Erectile impotence].
Topics: Erectile Dysfunction; Female; Gastrointestinal Diseases; Humans; Injections; Male; Papaverine; Penil | 1996 |
Early experience of corpora cavernosa electromyography in impotent patients after radical cystoprostatectomy.
Topics: Adult; Case-Control Studies; Cystectomy; Electromyography; Erectile Dysfunction; Humans; Male; Middl | 1996 |
Long-term follow-up of patients with erectile dysfunction commenced on self injection with intracavernosal papaverine with or without phentolamine.
Topics: Adult; Aged; Drug Combinations; Erectile Dysfunction; Follow-Up Studies; Humans; Injections; Male; M | 1996 |
A pilot study of the role of intracavernous injection of vasoactive intestinal peptide (VIP) and phentolamine mesylate in the treatment of erectile dysfunction.
Topics: Adult; Erectile Dysfunction; Humans; Impotence, Vasculogenic; Male; Middle Aged; Penile Erection; Pe | 1996 |
[Usefulness of the neuroandrologic profile study in patients with erectile dysfunction: review of a series of 180 cases].
Topics: Adult; Aged; Algorithms; Electromyography; Erectile Dysfunction; Evoked Potentials, Somatosensory; H | 1996 |
Corpus cavernosum electromyography (CC-EMG): a new technique in the diagnostic work-up of impotence.
Topics: Adolescent; Adult; Autonomic Pathways; Electromyography; Erectile Dysfunction; Humans; Male; Middle | 1996 |
Long-term follow-up of patients receiving injection therapy for erectile dysfunction.
Topics: Adult; Erectile Dysfunction; Follow-Up Studies; Humans; Injections, Subcutaneous; Male; Middle Aged; | 1997 |
Anxiety-induced failure in erectile response to intracorporeal prostaglandin-E1 in non-organic male impotence: a new diagnostic approach.
Topics: Adrenergic alpha-Antagonists; Alprostadil; Anxiety; Emotions; Erectile Dysfunction; Humans; Male; Pe | 1997 |
The value of a second injection on the pharmaco-induced erection test.
Topics: Adrenergic alpha-Antagonists; Alprostadil; Erectile Dysfunction; Humans; Injections; Male; Papaverin | 1997 |
[Evaluation of electromyography of the corpora cavernosa (single potential analysis of cavernous electric activity--SPACE) as a technique for studying impotence].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Electromyography; Erectile Dysfunction; Humans; Male; Mi | 1997 |
Vasoactive intestinal polypeptide and phentolamine mesylate administered by autoinjector in the treatment of patients with erectile dysfunction resistant to other intracavernosal agents.
Topics: Adolescent; Adult; Aged; Drug Combinations; Erectile Dysfunction; Humans; Injections; Male; Middle A | 1998 |
Drop-out reasons and complications in self-injection therapy with a triple vasoactive drug mixture in sexual erectile dysfunction.
Topics: Adult; Aged; Alprostadil; Erectile Dysfunction; Fibrosis; Humans; Male; Middle Aged; Papaverine; Pen | 1998 |
The effect of re-dosing of vasodilators on the intracavernosal pressure and on the penile rigidity.
Topics: Adult; Aged; Alprostadil; Blood Flow Velocity; Blood Pressure; Drug Therapy, Combination; Erectile D | 1998 |
Accumulation of platelets as a key mechanism of human erection. A scintigraphic study in patients with erectile dysfunction receiving intracavernous injection of PGE1, papaverine/phentolamine.
Topics: Adult; Aged; Alprostadil; Blood Platelets; Erectile Dysfunction; Humans; Indium Radioisotopes; Male; | 1997 |
Coincidence of induratio penis plastica and erectile dysfunction.
Topics: Adult; Aged; Diagnosis, Differential; Erectile Dysfunction; Follow-Up Studies; Humans; Injections, I | 1998 |
Penile fracture after intracavernous injection therapy.
Topics: Adult; Alprostadil; Drug Therapy, Combination; Erectile Dysfunction; Humans; Injections; Male; Papav | 1998 |
Role of radionuclide phallogram in therapeutic decision-making for erectile dysfunction.
Topics: Adult; Aged; Erectile Dysfunction; Erythrocytes; Humans; Male; Middle Aged; Papaverine; Penis; Phent | 1998 |
The impact of marital satisfaction and psychological counselling on the outcome of ICI-treatment in men with ED.
Topics: Erectile Dysfunction; Female; Humans; Injections; Male; Marriage; Papaverine; Patient Dropouts; Pati | 1998 |
Vasoactive cocktails for erectile dysfunction: chemical stability of PGE1, papaverine and phentolamine.
Topics: Adrenergic alpha-Antagonists; Alprostadil; Chromatography, High Pressure Liquid; Drug Combinations; | 1998 |
Hepatotoxicity related to intracavernous pharmacotherapy with papaverine.
Topics: Adult; Aged; Chemical and Drug Induced Liver Injury; Erectile Dysfunction; Follow-Up Studies; Humans | 1998 |
Short term use of intracavernous vasoactive drugs in the treatment of persistent psychogenic erectile dysfunction.
Topics: Adult; Alprostadil; Anxiety; Erectile Dysfunction; Humans; Male; Marriage; Middle Aged; Papaverine; | 1998 |
Comparison of Alprostadil (Caverject) and a combination of vasoactive drugs as local injections for the treatment of erectile dysfunction.
Topics: Alprostadil; Erectile Dysfunction; Humans; Injections; Male; Papaverine; Phentolamine; Sympatholytic | 1998 |
Progressive treatment of erectile dysfunction with intracorporeal injections of different combinations of vasoactive agents.
Topics: Adult; Aged; Aged, 80 and over; Alprostadil; Atropine; Erectile Dysfunction; Humans; Male; Middle Ag | 1999 |
Maximisation of the erectile response in the investigation of impotence.
Topics: Aged; Alprostadil; Audiovisual Aids; Erectile Dysfunction; Humans; Male; Middle Aged; Papaverine; Pe | 1999 |
Intracavernosal therapy for erectile failure--impact of treatment and reasons for drop-out and dissatisfaction.
Topics: Adult; Aged; Aged, 80 and over; Alprostadil; Coitus; Erectile Dysfunction; Humans; Injections; Libid | 1999 |
[Pharmaco-erection in erectile deficiency after surgical therapy].
Topics: Adrenergic alpha-Antagonists; Alprostadil; Cystectomy; Erectile Dysfunction; Humans; Injections; Mal | 1999 |
Comparison of the synergistic effects of tamsulosin versus phentolamine on penile erection: in vitro and in vivo studies.
Topics: Adrenergic alpha-Antagonists; Alprostadil; Animals; Blood Pressure; Dogs; Drug Synergism; Erectile D | 1999 |
Vasoactive intestinal peptide/phentolamine. Invicorp, vasopotin.
Topics: Clinical Trials as Topic; Drug Combinations; Erectile Dysfunction; Humans; Male; Middle Aged; Phento | 1999 |
Cost utility analysis of sildenafil compared with papaverine-phentolamine injections.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cost-Benefit Analysis; Drug Costs; Drug Therapy, Combina | 2000 |
In vitro effects of sildenafil and phentolamine, drugs used for erectile dysfunction, on human sperm motility.
Topics: Dose-Response Relationship, Drug; Erectile Dysfunction; Humans; Hydrogen-Ion Concentration; Kinetics | 2000 |
[Evaluation of 452 patients with erectile dysfunction treated by combinations of vasoactive agents by penile injection].
Topics: Adult; Aged; Aged, 80 and over; Alprostadil; Drug Therapy, Combination; Erectile Dysfunction; Humans | 1998 |
Re-dosing of prostaglandin-E1 versus prostaglandin-E1 plus phentolamine in male erectile dysfunction: a dynamic color power Doppler study.
Topics: Alprostadil; Erectile Dysfunction; Humans; Male; Phentolamine; Ultrasonography, Doppler, Color | 2000 |
Vasomax for the treatment of male erectile dysfunction.
Topics: Adrenergic alpha-Antagonists; Erectile Dysfunction; Humans; Male; Phentolamine | 2001 |
[Intracavernous auto-injection therapy with papaverine phentolamine via an auto-injection pen for patients with an erectile dysfunction: similar results achieved in family practice and urology].
Topics: Adrenergic alpha-Antagonists; Adult; Aged; Aged, 80 and over; Drug Combinations; Erectile Dysfunctio | 2001 |
The value of sildenafil as mode of stimulation in pharmaco-penile duplex ultrasonography.
Topics: Administration, Oral; Adult; Aged; Cross-Over Studies; Dose-Response Relationship, Drug; Drug Combin | 2001 |
Intracavernous injection in the treatment of erectile dysfunction after radical prostatectomy: an observational study.
Topics: Adult; Aged; Alprostadil; Erectile Dysfunction; Humans; Injections; Male; Middle Aged; Papaverine; P | 2001 |
Intracavernous injections: still the gold standard for treatment of erectile dysfunction in elderly men.
Topics: Aged; Aged, 80 and over; Aging; Alprostadil; Case-Control Studies; Dose-Response Relationship, Drug; | 2001 |
Synergistic effects of sildenafil on relaxation of rabbit and rat cavernosal smooth muscles when combined with various vasoactive agents.
Topics: Animals; Antihypertensive Agents; Cardiovascular Agents; Colforsin; Drug Synergism; Drug Therapy, Co | 2001 |
Short report: penile lymphoma following local injections for erectile dysfunction.
Topics: Drug Therapy, Combination; Erectile Dysfunction; Humans; Injections; Lymphoma, Large B-Cell, Diffuse | 2001 |
What nonresponse to intracavernous injection really indicates: a determination by quantitative analysis.
Topics: Adrenergic alpha-Antagonists; Adult; Age Factors; Alprostadil; Erectile Dysfunction; Humans; Injecti | 2002 |
Intracavernous injections for erectile dysfunction in patients with cardiovascular diseases and failure or contraindications for sildenafil citrate.
Topics: Adrenergic alpha-Antagonists; Adult; Aged; Aged, 80 and over; Alprostadil; Atropine; Cardiovascular | 2002 |
[Progress in therapy of erectile dysfunction. New orally administered drugs].
Topics: Administration, Oral; Apomorphine; Clinical Trials as Topic; Erectile Dysfunction; Humans; Male; Phe | 2002 |
The clinical effectiveness of self-injection and external vacuum devices in the treatment of erectile dysfunction: a six-month comparison.
Topics: Adult; Aged; Erectile Dysfunction; Follow-Up Studies; Humans; Male; Middle Aged; Papaverine; Penile | 1992 |
[Impotence: introductory notes].
Topics: Alprostadil; Erectile Dysfunction; Humans; Male; Papaverine; Penile Erection; Penile Prosthesis; Phe | 1992 |
[Intracavernous infusion of drugs].
Topics: Alprostadil; Erectile Dysfunction; Humans; Injections; Ketanserin; Male; Papaverine; Penis; Phentola | 1992 |
[Test with vasoactive drugs: its predictive value in the diagnosis of erectile sexual dysfunction of venous origin].
Topics: Adult; Aged; Erectile Dysfunction; Humans; Male; Middle Aged; Papaverine; Penis; Phentolamine; Predi | 1992 |
[Priapism induced by intracavernous injection].
Topics: Adult; Drug Therapy, Combination; Erectile Dysfunction; Humans; Injections; Male; Middle Aged; Papav | 1992 |
Penile revascularization in nonresponders to intracavernous injections using a modified microsurgical technique.
Topics: Alprostadil; Arteriovenous Shunt, Surgical; Erectile Dysfunction; Humans; Male; Microsurgery; Middle | 1992 |
Through the eyes of women: the sexual and psychological responses of women to their partner's treatment with self-injection or external vacuum therapy.
Topics: Coitus; Consumer Behavior; Erectile Dysfunction; Female; Humans; Male; Papaverine; Phentolamine; Pro | 1992 |
[Long-term results of corpus cavernosum auto-injection therapy in treatment of patients with chronic erectile dysfunction].
Topics: Dose-Response Relationship, Drug; Erectile Dysfunction; Humans; Injections; Long-Term Care; Male; Ma | 1992 |
Intracavernous self-injection with vasoactive intestinal polypeptide and phentolamine in the management of erectile failure.
Topics: Adult; Aged; Drug Administration Schedule; Drug Therapy, Combination; Erectile Dysfunction; Humans; | 1992 |
Patient satisfaction with pharmacologic erection program.
Topics: Adult; Alprostadil; Erectile Dysfunction; Humans; Male; Papaverine; Patient Satisfaction; Penile Ere | 1992 |
The role of intracavernous injection of vasoactive medications for the restoration of erection in spinal cord injured males: a three year follow up.
Topics: Adult; Aged; Erectile Dysfunction; Female; Humans; Injections; Male; Middle Aged; Papaverine; Penile | 1992 |
Penile pharmacological duplex ultrasonography: a dose-effect study comparing papaverine, papaverine/phentolamine and prostaglandin E1.
Topics: Aged; Alprostadil; Blood Flow Velocity; Dose-Response Relationship, Drug; Erectile Dysfunction; Huma | 1992 |
Factors predicting efficacy of phentolamine-papaverine intracorporeal injection for treatment of erectile dysfunction in diabetic male.
Topics: Age Factors; Diabetes Complications; Drug Therapy, Combination; Erectile Dysfunction; Humans; Male; | 1992 |
The role of intracavernosal vasoactive agents to overcome impotence due to spinal cord injury.
Topics: Adult; Alprostadil; Blood Pressure; Erectile Dysfunction; Humans; Injections; Male; Middle Aged; Pap | 1992 |
Classification of sexual dysfunction for management of intracavernous medication-induced erections.
Topics: Adult; Aged; Drug Combinations; Erectile Dysfunction; Humans; Male; Middle Aged; Papaverine; Penile | 1990 |
Treatment of male impotence: a new option.
Topics: Erectile Dysfunction; Humans; Injections; Male; Papaverine; Phentolamine | 1990 |
Intracavernous pharmacotherapy in psychogenic impotence.
Topics: Adult; Combined Modality Therapy; Drug Combinations; Erectile Dysfunction; Humans; Injections; Male; | 1991 |
An improved vasoactive drug combination for a pharmacological erection program.
Topics: Adult; Aged; Alprostadil; Drug Combinations; Erectile Dysfunction; Humans; Injections; Male; Middle | 1991 |
Digital subtraction cavernosography: method to detect venous leakage.
Topics: Angiography, Digital Subtraction; Cineradiography; Erectile Dysfunction; Humans; Male; Middle Aged; | 1991 |
Twelve-month comparison of two treatments for erectile dysfunction: self-injection versus external vacuum devices.
Topics: Coitus; Drug Therapy, Combination; Erectile Dysfunction; Follow-Up Studies; Humans; Injections; Male | 1992 |
Nuclear penogram can quantitate and record the effect of pharmacologic treatment of impotence.
Topics: Erectile Dysfunction; Humans; Male; Papaverine; Penile Erection; Phentolamine; Radionuclide Imaging | 1991 |
[Acceptance of corpus cavernosum auto-injection therapy in long-term treatment of erectile dysfunction].
Topics: Erectile Dysfunction; Follow-Up Studies; Humans; Injections, Intravenous; Long-Term Care; Male; Midd | 1991 |
[Intracavernous pharmacotherapy for treatment and evaluation of impotence].
Topics: Adult; Aged; Alprostadil; Erectile Dysfunction; Follow-Up Studies; Humans; Male; Middle Aged; Papave | 1991 |
Angiodynography (color-coded duplex sonography) in the evaluation of vasculogenic impotence.
Topics: Adult; Angiography; Arteries; Blood Flow Velocity; Erectile Dysfunction; Humans; Male; Middle Aged; | 1991 |
Induced priapism and its management.
Topics: Dopamine; Drug Therapy, Combination; Erectile Dysfunction; Humans; Injections; Male; Metaraminol; Pa | 1991 |
Controlled trial of infusion cavernosometry in impotent and potent men.
Topics: Blood Pressure; Case-Control Studies; Erectile Dysfunction; Humans; Male; Papaverine; Penile Erectio | 1991 |
Investigating male sexual dysfunction. Cavernosograms and penile flow studies.
Topics: Alprostadil; Arterial Occlusive Diseases; Erectile Dysfunction; Humans; Male; Papaverine; Penile Ere | 1991 |
Calcitonin-gene-related peptide: a possible role in human penile erection and its therapeutic application in impotent patients.
Topics: Adult; Aged; Alprostadil; Calcitonin Gene-Related Peptide; Erectile Dysfunction; Humans; Male; Middl | 1991 |
Pharmacologically induced erections among geriatric men.
Topics: Adult; Age Factors; Aged; Drug Therapy, Combination; Erectile Dysfunction; Female; Humans; Injection | 1991 |
Sexual, psychological, and marital impact of self-injection of papaverine and phentolamine: a long-term prospective study.
Topics: Adaptation, Psychological; Erectile Dysfunction; Follow-Up Studies; Humans; Injections; Male; Marria | 1991 |
Postoperative erectile dysfunction; evaluation and treatment with intracavernous vasoactive injections.
Topics: Aged; Drug Combinations; Erectile Dysfunction; Humans; Injections; Male; Middle Aged; Papaverine; Pe | 1991 |
Gluteal device for penile injection.
Topics: Drug Therapy, Combination; Erectile Dysfunction; Humans; Infusion Pumps, Implantable; Male; Methods; | 1991 |
Venous leaks: anatomical and physiological observations.
Topics: Adult; Aged; Erectile Dysfunction; Hemodynamics; Humans; Male; Middle Aged; Papaverine; Penile Erect | 1991 |
Intracavernous injection of prostaglandin E1 in combination with papaverine: enhanced effectiveness in comparison with papaverine plus phentolamine and prostaglandin E1 alone.
Topics: Adult; Alprostadil; Drug Evaluation; Drug Therapy, Combination; Erectile Dysfunction; Humans; Inject | 1991 |
Infusion pharmacocavernosometry and nocturnal penile tumescence findings in men with erectile dysfunction.
Topics: Adult; Aged; Erectile Dysfunction; Humans; Infusions, Parenteral; Male; Middle Aged; Papaverine; Pen | 1991 |
[Treatment of erection disorders].
Topics: Erectile Dysfunction; Humans; Male; Papaverine; Penile Erection; Phentolamine; Prostaglandins; Prost | 1991 |
The combined use of sex therapy and intrapenile injections in the treatment of impotence.
Topics: Adult; Alprostadil; Combined Modality Therapy; Erectile Dysfunction; Female; Humans; Injections; Mal | 1990 |
[Corpus cavernosum injection treatment of erectile impotence].
Topics: Adult; Aged; Drug Therapy, Combination; Erectile Dysfunction; Humans; Injections, Intravenous; Male; | 1990 |
[Pharmacocavernosometry and pharmacocavernosography in erectile dysfunction].
Topics: Alprostadil; Blood Flow Velocity; Erectile Dysfunction; Humans; Male; Papaverine; Penile Erection; P | 1990 |
[Intracavernous pharmacotherapy for organic impotence in the elderly].
Topics: Aged; Aged, 80 and over; Drug Therapy, Combination; Erectile Dysfunction; Humans; Injections; Male; | 1990 |
Intracavernous injections for impotence.
Topics: Alprostadil; Erectile Dysfunction; Humans; Injections; Male; Papaverine; Penis; Phentolamine; Self A | 1990 |
Intracavernous drug delivery system: an alternative to intracavernous injection in the treatment of impotence?
Topics: Animals; Drug Combinations; Erectile Dysfunction; Fibrosis; Infusion Pumps, Implantable; Macaca fasc | 1990 |
Intracavernous injection therapy: analysis of results and complications.
Topics: Drug Therapy, Combination; Erectile Dysfunction; Fibrosis; Hematoma; Humans; Male; Middle Aged; Papa | 1990 |
The use of vasoactive agents in the treatment of erectile impotence.
Topics: Adult; Aged; Aged, 80 and over; Erectile Dysfunction; Humans; Injections; Male; Middle Aged; Papaver | 1990 |
Diagnostic and therapeutic technology assessment. Vasoactive intracavernous pharmacotherapy for impotence: papaverine and phentolamine.
Topics: American Medical Association; Erectile Dysfunction; Humans; Injections; Male; Papaverine; Penile Ere | 1990 |
[Priapism following intracavernous injection of vasoactive substances as a urologic emergency].
Topics: Adult; Aged; Drug Therapy, Combination; Emergencies; Erectile Dysfunction; Humans; Male; Metaraminol | 1990 |
[Corpus cavernosum autoinjection therapy: initial experiences in erectile dysfunction].
Topics: Drug Therapy, Combination; Erectile Dysfunction; Humans; Injections; Male; Papaverine; Penis; Phento | 1986 |
[Metaraminol--an antidote in corpus cavernosum autoinjection therapy-induced prolonged erection].
Topics: Adult; Drug Therapy, Combination; Erectile Dysfunction; Humans; Injections; Male; Metaraminol; Papav | 1986 |
[Corpus cavernosum autoinjection therapy--a new concept in the treatment of erectile dysfunction].
Topics: Adult; Drug Therapy, Combination; Erectile Dysfunction; Humans; Injections, Intravenous; Male; Middl | 1986 |
Pharmacologic erection program for the treatment of male impotence.
Topics: Drug Therapy, Combination; Erectile Dysfunction; Humans; Injections; Male; Papaverine; Penile Erecti | 1987 |
Studies on intracavernosal VIP levels during pharmacologically induced penile erections.
Topics: Erectile Dysfunction; Humans; Male; Papaverine; Penile Erection; Phentolamine; Vasoactive Intestinal | 1987 |
Pharmacological erection: diagnosis and treatment applications in 69 patients.
Topics: Drug Combinations; Erectile Dysfunction; Humans; Male; Papaverine; Penile Erection; Penis; Phentolam | 1987 |
Fibrosis of tunica albuginea: complication of long-term intracavernous pharmacological self-injection.
Topics: Aged; Drug Combinations; Erectile Dysfunction; Fibrosis; Humans; Male; Middle Aged; Papaverine; Peni | 1987 |
Intracavernosal injection in the treatment of impotence: a prospective study of sexual, psychological, and marital functioning.
Topics: Erectile Dysfunction; Humans; Injections; Male; Middle Aged; Orgasm; Papaverine; Penile Erection; Ph | 1987 |
[2 years' experiences with cavernosal autoinjection therapy].
Topics: Drug Therapy, Combination; Erectile Dysfunction; Humans; Injections; Male; Metaraminol; Papaverine; | 1987 |
Mid-term results of autoinjection therapy for erectile dysfunction.
Topics: Dose-Response Relationship, Drug; Drug Evaluation; Drug Therapy, Combination; Erectile Dysfunction; | 1988 |
Utility of Rigiscan and papaverine in diagnosis of erectile impotence.
Topics: Erectile Dysfunction; Evaluation Studies as Topic; Humans; Male; Monitoring, Physiologic; Papaverine | 1988 |
[Intracavernous injection of vasoactive drugs for treating erectile impotence].
Topics: Aged; Alprostadil; Erectile Dysfunction; Humans; Injections; Male; Middle Aged; Papaverine; Penile E | 1988 |
Physicochemical stability of papaverine hydrochloride-phentolamine mesylate mixtures used for intracavernous injection: a preliminary evaluation.
Topics: Drug Combinations; Drug Stability; Drug Storage; Erectile Dysfunction; Humans; Male; Papaverine; Pen | 1988 |
[Experience with chemical prosthesis in impotence: report of 138 cases].
Topics: Adult; Aged; Erectile Dysfunction; Humans; Injections; Male; Middle Aged; Papaverine; Penis; Phentol | 1988 |
Injections of papaverine and regitine into the corpora cavernosa for erectile dysfunction: clinical results in 60 patients.
Topics: Adult; Aged; Drug Therapy, Combination; Erectile Dysfunction; Humans; Male; Middle Aged; Papaverine; | 1989 |
[Diagnosis and treatment of impotence with administration of chemical prosthesis using real-time mechanical sector duplex scanner--with special reference to diabetic patients].
Topics: Adult; Aged; Diabetes Complications; Erectile Dysfunction; Humans; Male; Middle Aged; Papaverine; Pe | 1989 |
Alpha-adrenoceptor function in isolated penile circumflex veins from potent and impotent men.
Topics: Adult; Aged; Erectile Dysfunction; Humans; In Vitro Techniques; Male; Middle Aged; Muscle Contractio | 1989 |
Auto-injection of the corpus cavernosum with a vasoactive drug combination for vasculogenic impotence.
Topics: Aged; Coitus; Drug Combinations; Erectile Dysfunction; Humans; Male; Middle Aged; Papaverine; Penis; | 1985 |
Intracavernous pharmacotherapy for management of erectile dysfunction in spinal cord injury.
Topics: Adult; Dose-Response Relationship, Drug; Erectile Dysfunction; Humans; Male; Middle Aged; Papaverine | 1989 |
Vascular insufficiency: a significant factor in impotence.
Topics: Alprostadil; Erectile Dysfunction; Humans; Male; Papaverine; Penile Prosthesis; Penis; Phentolamine | 1989 |
[Diagnosis of venous insufficiency in erectile dysfunction: comparative studies of cavernosonography and Doppler sonography].
Topics: Blood Flow Velocity; Erectile Dysfunction; Humans; Male; Papaverine; Penis; Phentolamine; Ultrasonog | 1989 |
[Prostaglandin E1 in erectile dysfunction].
Topics: Alprostadil; Blood Flow Velocity; Drug Therapy, Combination; Erectile Dysfunction; Humans; Injection | 1989 |
Intra-individual comparative study of dynamic and pharmacocavernography.
Topics: Blood Flow Velocity; Erectile Dysfunction; Humans; Male; Papaverine; Penile Erection; Penis; Phentol | 1989 |
[Pharmaco-cavernosonography and cavernosometry with a new roller pump (AP 300 C)].
Topics: Erectile Dysfunction; Humans; Male; Papaverine; Penile Erection; Phentolamine; Ultrasonography; Veno | 1989 |
Treatment of persistent penile erection and priapism using terbutaline.
Topics: Adult; Aged; Erectile Dysfunction; Humans; Male; Middle Aged; Papaverine; Penile Erection; Phenoxybe | 1989 |
The pH analysis of papaverine-phentolamine and prostaglandin E1 for pharmacologic erection.
Topics: Alprostadil; Buffers; Chemical Phenomena; Chemistry; Drug Combinations; Drug Stability; Erectile Dys | 1989 |
Effects of intracavernosal pharmacotherapy on self-esteem, performance anxiety and partnership in patients with chronic erectile dysfunction.
Topics: Anxiety; Coitus; Drug Combinations; Erectile Dysfunction; Humans; Male; Papaverine; Penile Erection; | 1989 |
Penile response to intracavernosal vasoactive intestinal polypeptide alone and in combination with other vasoactive agents.
Topics: Adult; Aged; Drug Therapy, Combination; Erectile Dysfunction; Humans; Male; Middle Aged; Papaverine; | 1989 |
Why do so many people drop out from auto-injection therapy for impotence?
Topics: Erectile Dysfunction; Male; Papaverine; Patient Dropouts; Phentolamine; Retrospective Studies; Self | 1989 |
Intracavernous injections of papaverine and phentolamine: correlation with penile brachial index.
Topics: Adult; Aged; Aged, 80 and over; Drug Combinations; Erectile Dysfunction; Humans; Male; Middle Aged; | 1989 |
[3 years' experience with intracavernous auto-injection therapy].
Topics: Adult; Aged; Alprostadil; Drug Therapy, Combination; Erectile Dysfunction; Humans; Injections; Male; | 1989 |
Quantitative and qualitative analysis of dynamic cavernosographies in erectile dysfunction due to venous leakage.
Topics: Adult; Erectile Dysfunction; Humans; Male; Middle Aged; Papaverine; Penile Erection; Penis; Phentola | 1989 |
Enhanced cavernometry: procedure for the diagnosis of venogenic impotence.
Topics: Adolescent; Adult; Aged; Erectile Dysfunction; Humans; Male; Methods; Middle Aged; Papaverine; Penis | 1989 |
Side effects of self-administration of intracavernous papaverine and phentolamine for the treatment of impotence.
Topics: Adult; Aged; Drug Therapy, Combination; Erectile Dysfunction; Humans; Injections; Liver Function Tes | 1989 |
[Papaverine-induced priapism. Experiences with a new urologic emergency].
Topics: Adult; Bloodletting; Combined Modality Therapy; Dose-Response Relationship, Drug; Emergencies; Erect | 1989 |
[Dynamic cavernosonography and intracavernous drug testing in the diagnosis of erectile dysfunction].
Topics: Adolescent; Adult; Aged; Angiography; Erectile Dysfunction; Humans; Male; Middle Aged; Papaverine; P | 1987 |
Diagnostic accuracy of Doppler ultrasound technique of the penile arteries in correlation to selective arteriography.
Topics: Angiography; Arteries; Erectile Dysfunction; Humans; Male; Middle Aged; Papaverine; Penile Erection; | 1988 |
[Disorders of erectile potency in diabetes mellitus].
Topics: Aged; Alprostadil; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diab | 1988 |
Impotence: treatment by autoinjection of vasoactive drugs.
Topics: Adult; Aged; Drug Combinations; Erectile Dysfunction; Humans; Injections; Male; Middle Aged; Papaver | 1987 |
Impotence: treatment by autoinjection of vasoactive drugs.
Topics: Drug Therapy, Combination; Erectile Dysfunction; Humans; Male; Papaverine; Phentolamine; Self Admini | 1987 |
Impotence: treatment by autoinjection of vasoactive drugs.
Topics: Drug Therapy, Combination; Erectile Dysfunction; Female; Humans; Male; Papaverine; Phentolamine | 1987 |
Pharmacoangiographic assessment of the corpora cavernosa.
Topics: Angiography; Erectile Dysfunction; Humans; Male; Papaverine; Penile Erection; Penis; Phentolamine; V | 1988 |
Therapeutic roles of intracavernosal papaverine.
Topics: Erectile Dysfunction; Humans; Injections; Male; Papaverine; Penile Erection; Phentolamine; Self Admi | 1988 |
Is phentolamine stable in solution with papaverine.
Topics: Chromatography, High Pressure Liquid; Drug Combinations; Drug Stability; Erectile Dysfunction; Gas C | 1988 |
Intracavernous self-injection for impotence: a long-term therapeutic option? Experience in 78 patients.
Topics: Consumer Behavior; Drug Combinations; Erectile Dysfunction; Humans; Male; Middle Aged; Pain; Papaver | 1988 |
The use of a vacuum constrictor device to augment a partial erection following an intracavernous injection.
Topics: Adult; Aged; Constriction; Drug Combinations; Equipment Design; Erectile Dysfunction; Humans; Male; | 1988 |
Erectile responses to intracavernous papaverine and phentolamine: comparison of single and combined delivery.
Topics: Adult; Drug Therapy, Combination; Erectile Dysfunction; Humans; Injections; Male; Middle Aged; Papav | 1988 |
Experience in the management of erectile dysfunction using the intracavernosal self-injection of vasoactive drugs.
Topics: Adult; Aged; Drug Therapy, Combination; Erectile Dysfunction; Follow-Up Studies; Humans; Injections; | 1988 |
Intracavernous self-injection for erectile failure.
Topics: Adult; Aged; Consumer Behavior; Drug Therapy, Combination; Erectile Dysfunction; Humans; Male; Middl | 1988 |
Diagnosis and treatment of venous leakage: a curable cause of impotence.
Topics: Adult; Erectile Dysfunction; Humans; Male; Middle Aged; Papaverine; Penile Erection; Penis; Phentola | 1988 |
[Value of prostaglandin El in the diagnosis of erectile dysfunction in comparison with papaverine and papaverine/phentolamine in 61 patients with erectile dysfunction].
Topics: Adult; Aged; Alprostadil; Blood Flow Velocity; Drug Combinations; Erectile Dysfunction; Humans; Male | 1988 |
Functional evaluation of penile hemodynamics.
Topics: Adult; Aged; Erectile Dysfunction; Hemodynamics; Humans; Male; Middle Aged; Papaverine; Penile Erect | 1988 |
Pharmacological treatment of erectile dysfunction after radical prostatectomy.
Topics: Drug Combinations; Erectile Dysfunction; Humans; Male; Papaverine; Penile Erection; Phentolamine; Po | 1988 |
Intracavernous injection of vasoactive drugs after radical prostatectomy.
Topics: Erectile Dysfunction; Humans; Male; Papaverine; Penile Erection; Phentolamine; Prostatectomy | 1988 |
The management of impotence following pelvic surgery.
Topics: Erectile Dysfunction; Humans; Male; Papaverine; Penile Erection; Penis; Phentolamine; Postoperative | 1988 |
[Results and acceptance of corpus cavernosum autoinjection therapy in organic erectile dysfunction].
Topics: Erectile Dysfunction; Humans; Injections; Male; Papaverine; Patient Acceptance of Health Care; Penil | 1988 |
[Intracavernous injection of vasoactive substances in the treatment of erectile dysfunction].
Topics: Dose-Response Relationship, Drug; Drug Therapy, Combination; Erectile Dysfunction; Humans; Injection | 1988 |
[Experience in the treatment of erectile impotence by the intracavernous auto-injection of vasoactive substances].
Topics: Adult; Coitus; Erectile Dysfunction; Humans; Male; Middle Aged; Papaverine; Penile Erection; Phentol | 1988 |
Oral phentolamine in nonspecific erectile insufficiency.
Topics: Administration, Oral; Erectile Dysfunction; Humans; Male; Penile Erection; Phentolamine | 1988 |
Treatment of male impotence--a pharmacologic erection program.
Topics: Adult; Aged; Aged, 80 and over; Ambulatory Care; Drug Therapy, Combination; Erectile Dysfunction; Fo | 1988 |
Intracavernosal injection therapy for impotence: preliminary results.
Topics: Adult; Aged; Drug Combinations; Erectile Dysfunction; Humans; Injections; Male; Middle Aged; Papaver | 1988 |
Impotence. Assessment in the private-practice office.
Topics: Erectile Dysfunction; Humans; Injections; Male; Papaverine; Penis; Phentolamine; Prostheses and Impl | 1988 |
Intracavernous injection of papaverine, phentolamine and phenoxybenzamine.
Topics: Adult; Erectile Dysfunction; Humans; Injections; Male; Middle Aged; Papaverine; Penis; Phenoxybenzam | 1988 |
Nocturnal computed rigidity and tumescence evaluation in the prevention of the iatrogenic priapism.
Topics: Adult; Drug Therapy, Combination; Erectile Dysfunction; Humans; Male; Middle Aged; Papaverine; Penil | 1988 |
Prolonged erections following intracorporeal injection of medications to overcome impotence.
Topics: Adult; Aged; Erectile Dysfunction; Humans; Male; Metaraminol; Middle Aged; Papaverine; Phenoxybenzam | 1988 |
Nocturnal penile tumescence predicting response to intracorporeal pharmacological erection testing.
Topics: Adult; Aged; Erectile Dysfunction; Humans; Male; Middle Aged; Papaverine; Penile Erection; Phentolam | 1988 |
Intracavernous self-injection of papaverine and regitine for the treatment of organic impotence.
Topics: Adult; Aged; Drug Combinations; Erectile Dysfunction; Humans; Injections; Male; Middle Aged; Papaver | 1986 |
A new alternative in evaluating and treating impotence in men: direct injections of the corpora cavernosa.
Topics: Drug Therapy, Combination; Erectile Dysfunction; Humans; Injections; Male; Papaverine; Penis; Phento | 1987 |
Physiology of erection and pharmacological management of impotence.
Topics: Animals; Drug Combinations; Erectile Dysfunction; Humans; Male; Papaverine; Penile Erection; Penis; | 1987 |
Penile pharmacocavernosography and cavernosometry in the evaluation of impotence.
Topics: Adult; Aged; Aged, 80 and over; Erectile Dysfunction; Humans; Male; Middle Aged; Papaverine; Penis; | 1987 |
Information and treatment with intracavernous injections of papaverine and phentolamine.
Topics: Drug Therapy, Combination; Erectile Dysfunction; Humans; Male; Papaverine; Phentolamine; Self Admini | 1987 |
Treatment of impotence. 1. Nonsurgical methods.
Topics: Bromocriptine; Erectile Dysfunction; Humans; Male; Papaverine; Phentolamine; Psychotherapy; Self Adm | 1987 |
Dynamic corpus cavernosography: effect of papaverine injection.
Topics: Adult; Aged; Blood Pressure; Chronic Disease; Cineradiography; Diatrizoate Meglumine; Erectile Dysfu | 1987 |
Cavernosal venocclusive insufficiency in male impotence: evaluation of degree and location.
Topics: Aged; Blood Pressure; Erectile Dysfunction; Humans; Male; Manometry; Middle Aged; Papaverine; Penile | 1987 |
The application of intracavernous injection of vasoactive medications for erection in men with spinal cord injury.
Topics: Adult; Drug Combinations; Erectile Dysfunction; Humans; Male; Middle Aged; Papaverine; Penile Erecti | 1987 |
Penile self-injection for impotence in patients after radical cystectomy-ileal loop.
Topics: Drug Combinations; Erectile Dysfunction; Humans; Ileum; Male; Papaverine; Penile Erection; Phentolam | 1987 |
The management of erectile impotence.
Topics: Erectile Dysfunction; Humans; Male; Papaverine; Penile Erection; Phentolamine; Prostheses and Implan | 1986 |
Intracavernous injections for impotence.
Topics: Erectile Dysfunction; Humans; Male; Papaverine; Penile Erection; Phentolamine | 1987 |
[Spongious autoinjection therapy following implantation of a penis prosthesis--case report].
Topics: Aged; Drug Therapy, Combination; Erectile Dysfunction; Humans; Injections; Male; Papaverine; Penis; | 1987 |
Intracavernous injection of vasoactive drugs, an alternative for treating impotence in spinal cord injury patients.
Topics: Drug Combinations; Erectile Dysfunction; Humans; Injections; Male; Papaverine; Penis; Phentolamine; | 1986 |
[Preliminary results of the treatment of erectile impotence by intracavernous self administration of vasoactive substances].
Topics: Adult; Drug Combinations; Erectile Dysfunction; Humans; Injections; Male; Middle Aged; Papaverine; P | 1986 |
Pharmacologic injection therapy.
Topics: Erectile Dysfunction; Humans; Injections; Male; Papaverine; Penile Erection; Phentolamine; Self Admi | 1986 |
Treatment of prolonged or priapistic erections following intracavernosal papaverine therapy.
Topics: Erectile Dysfunction; Humans; Injections; Male; Papaverine; Penile Erection; Phentolamine; Priapism; | 1986 |
Intracorporal injection of papaverine and phentolamine in the management of impotence.
Topics: Adult; Aged; Drug Therapy, Combination; Erectile Dysfunction; Humans; Injections; Male; Middle Aged; | 1986 |
Fibrosis of corpus cavernosum after intracavernous injection of phentolamine/papaverine.
Topics: Adult; Drug Combinations; Erectile Dysfunction; Fibrosis; Humans; Injections; Male; Papaverine; Peni | 1987 |
Assessment of the immediate and long-term effects of pharmacologically induced penile erections in the treatment of psychogenic and organic impotence.
Topics: Adult; Aged; Drug Therapy, Combination; Erectile Dysfunction; Humans; Male; Middle Aged; Papaverine; | 1987 |
Intracavernous injections of vasoactive substances for the treatment of impotence.
Topics: Erectile Dysfunction; Humans; Injections; Male; Papaverine; Penis; Phentolamine; Vasodilator Agents | 1985 |
Cavernosal alpha blockade: a treatment for erectile impotence.
Topics: Erectile Dysfunction; Humans; Male; Papaverine; Phentolamine | 1986 |